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8 Abbreviations
List of abbreviations
•	 3C		 	 Chromosome	Conformation	Capture
•	 4C	 	 Chromosome	Conformation	Capture	on	Chip
•	 ACH	 	 Active	Chromatin	Hub
•	 APC/C		 Anaphase	Promoting	Complex	or	Cyclosome
•	 ATP	 	 Adenosine	triphosphate
•	 Bp	 	 Base	pairs
•	 CAR	 	 Cohesin-associated	regions
•	 CdLS	 	 Cornelia	de	Lange	Sydrome
•	 CH	 	 Chromatin	Hub
•	 Chip	 	 Chromatin	immuno-precipitation
•	 Chip-seq	 Chromatin	immuno-precipitation	and	direct	sequencing
•	 CTCF	 	 CCCCTC-binding	factor
•	 DNA	 	 Deoxyribonucleic	acid
•	 DNAaseI	 Deoxyribonuclease	I
•	 DSB	 	 DNA	double-strand	break
•	 EB	 	 Enhancer	blocker
•	 FISH	 	 Fluorescent	in	situ	hybridization
•	 HAT	 	 Histone	acetyltransferase
•	 HDAC	 	 Histone	deacetylase
•	 HP1	 	 Heterochromatin	protein	1
•	 HR	 	 Homologous	recombination
•	 HS	 	 Hypersensitive	site
•	 ICR	 	 Imprinting	control	region
•	 IL	 	 Interleukin
•	 KO	 	 Knockout
•	 LCR	 	 Locus	control	region
•	 LPS	 	 Lipopolysaccharides
•	 Mb	 	 Mega	base
•	 MEL	 	 Mouse	erythroleukemia
•	 MTA1	 	 Metastasis	tumor	antigen	1
•	 NIPBL	 	 Nipped-B	Like	Protein
•	 PCR	 	 Polymerase	chain	reaction
•	 PEV	 	 Position	effect	variegation
•	 RNA		 	 Ribonucleic	acid
•	 SHH	 	 Sonic	Hedgehog
•	 SMC	 	 Structural	Maintenance	of	Chromosomes
•	 SIR	 	 Silent	information	regulator
•	 Th-1/2	 	 T	helper	type-1/2	 	 	 	 	
9Aim	of	the	thesis
the aim of the thesis
In	 the	DNA	 of	metazoans,	 long-range	 interactions	 between	 distant	 regulatory	
elements	 are	 responsible	 for	 specific	 gene	 expression	 in	 many	 developmentally	
regulated	 genes	 and	 gene	 families.	 Gene-regulatory	 mechanisms	 are	 usually	
complex	 and	 involve	 the	 interaction	 of	 control	 elements	 such	 as	 enhancers	 with	
















Delangin	 (Nipped-B)	protein	 is	 involved	 in	 loading	of	Cohesin	onto	chromatin	
thereby	 playing	 an	 important	 role	 in	 chromatin	 dynamics.	 The	 role	 of	 Delangin	







chromosome	 conformation	 at	 several	 loci.	 The	 studies	 presented	 in	 the	 Chapter	




















proper	 spatio-temporal	 expression	 of	 genes	 throughout	 the	 process	 of	 cellular	
differentiation.	 These	 processes	 are	 coordinated	 by	 interactions	 of	 an	 “army”	 of	
general,	cell-type	and	stage	specific	proteins	that	bind	to	chromatin	and	DNA.
Several	techniques	allow	the	identification	and	study	of	chromatin	regions	that	





mediated	by	 insulators	and	other	 regulatory	 sequences,	 including	enhancers	and	
promoters,	which	mediate/promote	certain	functional	three-dimensional	interactions	
while	preventing	other	enhancer-promoter	contacts.	 In	 this	chapter,	 I	will	 introduce	
several	factors:	Ldb1,	Delangin,	Cohesin	and	CTCF	which	have	important	role	long-
range	interactions.	
1.  Cis-regulatory elements and gene regulation
Regulatory	sequences	that	are	encoded	in	the	primary	DNA	sequence	provide	
the	 first	 level	of	 transcriptional	control.	Several	distinct	cis-regulatory	elements	are	
identified	 including	 promoters,	 enhancers,	 silencers,	 Locus	 Control	 region	 (LCR)	
and	insulators.		These	so-called	cis	regulatory	elements,	attract	general	and	specific	
transcription	factors	that	are	responsible	for	the	functional	and	structural	organization	
of	 chromatin.	 They	 are	 relatively	 small	 DNA	 fragments	 (200-300bp)	 that	 contain	
information	“when,	where	and	how	much”	should	be	made	of	a	gene	product	encoded	
in	 the	primary	DNA	sequence.	This	 information	 is	used	by	 the	RNA	polymerase	 II	





In	 a	 structural	 sense,	 enhancers	 and	 promoters	 are	 quite	 similar.	 The	 main	
differences	 between	 their	 sequences	 and	 their	 location	 are	 that	 the	 sequence	 of	
enhancers	is	usually	longer	than	that	of	promoters	and	that	enhancers	can	be	located	
tens	 or	 hundreds	 of	 kilobases	 away	 from	 the	 genes	 whose	 activity	 they	 control.	
Furthermore,	enhancer	activity	is	not	dependent	on	orientation.	
One	 of	 the	 most	 spectacular	 examples	 of	 transcriptional	 control	 over	 long	









According	 to	 the	 current	 view,	 the	 factors	 participating	 in	 transcription	 are	
recruited	 to	 the	 activated	 promoter	 via	 protein-protein	 interactions	 (Ptashne	 and	
Gann,	1997).	The	enhancer-bound	activator	proteins	increase	the	local	concentration	
of	the	transcriptional	machinery	near	the	promoter.	In	higher	organisms,	long-distance	




strictly	 linear	manner.	Hence,	 there	must	be	mechanisms	 that	allow	 long-distance	
enhancer-promoter	 interactions.	 There	 are	 several	 different	 models	 proposed	 for	
enhancer	action	over	distance	which	are	not	mutually	exclusive.	The	combination	
of	 different	models	 is	 used	 to	 explain	 data	 generated	 at	 different	 loci	 in	 different	
organisms.
The	looping	model:
For	 many	 years	 after	 the	 discovery	 that	 enhancers	 are	 separated	 from	 the	
genes,	it	was	believed	that	enhancers	and	promoters	interact	irrespective	of	the	DNA	
between	 them.	A	 loop	of	DNA	would	be	 formed,	which	otherwise	would	separate	
promoter	 and	 enhancer	 on	 a	 one	 dimensional	 level	 (Ptashne,	 1986).	 In	 higher	
organisms,	where	gene	clusters	have	complex	regulation,	a	number	of	observations	









for	a	single	 regulator.	For	example,	 in	 transfection	assays	where	plasmids	contain	
different	 genes	 and	 enhancers,	 it	 was	 shown	 that	 genes	 compete	 for	 regulatory	
sequences	(Wasylyk	et	al.,	1983).	Such	competition	also	operates	 in	endogenous	























the	 recovery	 of	 associated	 protein	 (RNA	 TRAP)	 assay	 (Carter	 et	 al.,	 2002)	 and	






















and	HNF-3β	enhancer	binding	proteins	at	 the	HNF-4α	gene	 locus,	 these	proteins	
could	be	detected	at	the	spacer	DNA	as	well	as	at	the	promoter.	The	proteins	were	
bound	after	activation	of	 the	enhancer,	but	before	actual	 transcription	of	 the	gene	
(Hatzis	and	Talianidis,	2002).	Since	the	enhancer-promoter	communication	is	a	slow	























is	 usually	 altered.	 This	 is	 caused	 by	 the	 inability	 of	 the	 transgenic	 construct	
to	 overcome	 the	 local	 effects	 of	 chromatin	 structure	 at	 the	 site	 of	 the	 integration	
(position	effects).	 	 In	 the	1980s,	 transgenic	mouse	studies	using	human β-globin 
gene	construct	led	to	the	discovery	of	the	locus	control	region	(LCR).		It	is	a	dominant	




















leads	 to	 premature	 β-globin	 gene	 activation	 and	 reduction	 of	 γ-gene	 expression	
(Hanscombe	et	al.,	1991).
The	 competition	 between	genes	 in	 the β-globin	 locus	 suggests	 that	 the	 LCR	
functions	by	physical	interaction	with	the	genes.	After	the	discovery	of	the	β-globin	

































that	 exist	 as	 large	 regions	 of	 condensed	 chromatin.	 Chromatin	 is	 compacted	 by	
condensation	processes	that	are	self-propagating	and	can	spread	into	neighboring	
loci	affecting	their	expression	(Ghirlando	et	al.,	2004).	Therefore,	mechanisms	must	









silencing	a	gene	and	enhancer	blocking	 (EB)	 insulators	 (Figure	2),	which	prevent	
communication	 between	 discrete	 sequence	 elements	 (typically	 enhancers	 and	
promoters)	when	positioned	between	them	(Wallace	and	Felsenfeld,	2007).
	 Much	 of	 the	 early	 work	 that	 characterized	 insulator	 elements	 was	 done	 in	
Drosophila.	 The	 first	 DNA	 sequences	 to	 be	 described	 to	 have	 the	 	 properties	 of	
an	 insulator	 were	 the	 specialized	 chromatine	 structure	 (scs	 and	 scs’)	 elements.	
These	elements	were	 initially	 identified	as	DNAse	 I	HSS	 	 that	mark	 the	chromatin	
boundaries	of	a	heat	shock	locus	(Udvardy	et	al.,	1985).	Moreover,	it	was	shown	that	
these	 elements	 could	block	 an	 enhancer	 from	activating	 a	promoter	 (Kellum	and	
Schedl,	1992).	Several	DNA	binding	proteins	have	been	shown	to	bind	to	insulator	






	 Sequences	 that	 are	 able	 to	 act	 as	 insulators	 were	 identified	 later	 in	 other	
organisms	but	no	significant	similarity	 is	evident	among	these	proteins	(Bell	et	al.,	





genes	seems	 to	be	 less	obvious,	 there	are	well-established	examples	of	 insulator	
mediated	gene	regulation	in	mammals.	The	first	vertebrate	insulator	described	was	










There	 are	 several	 models	 explaining	 how	 an	 enhancer-blocking	 insulators	
influence	communication	between	enhancers	and	promoters.	The	models	are	not	
mutually	exclusive	and	potentially	any	insulator	could	employ	one	or	a	combination	









Insulators	 have	 been	 experimentally	 identified	 based	 on	 two	 defining	 characteristics:	 enhancer	
blocking	function	and	boundary	function.
A.	 Enhancer-blocker:	 an	 enhancer	 (E,	 blue	 box)	 can	 activate	 transcription	 (arrow)	 from	 a	
promoter	(P,	red	ellipse)	of	a	cis-linked	gene	(grey	rectangle)	.The	enhancer	activity	is	blocked	when	
an	insulator	element	(I,	yellow	oval)	is	positioned	in	between	the	enhancer	and	promoter.
B.	 Boundary	 element:	 spreading	 of	 nearby	 heterochromatin	 into	 a	 locus	 prevents	 the	

















activity	 is	 linked	 to	 a	 disruption	 of	 the	 reaction	 responsible	 for	 heterochromatin	
spreading.	 In	 these	models,	 the	 barriers	 function	 as	 	 chain	 terminators	 by	 either	
modulating	 the	 nucleosomal	 structure	 or	 by	 formation	 of	 looped	 structures	 by	
anchoring	the	chromatin	fiber	(Gaszner	and	Felsenfeld,	2006).	For	example,	the	cHS4	
vertebrate	 insulator	 recruits	 histone	 acetyltransferase	 (HAT)	 and	methytransferase	
which	 leads	 to	histone	modifications	and	eventual	 termination	of	 heterochromatin	
formation	(West	et	al.,	2004).	Although	histone	modification	is	a	necessary	step	for	
insulation	in	cHS4,	it	is	not	sufficient	to	block	heterochromatin	spreading.	Additional	
protein	 binding	 sites	 in	 cHS4	without	 histone	modification	marks	 are	 required	 for	
complete	boundary	activity	(West	et	al.,	2004).
2. the Role of CtCF in long-range interactions
The	complex	 three-dimensional	organization	of	gene	 regulation	 raises	several	












that	 are	escaping	X-inactivation	 (Filippova	et	 al.,	 2005).	How	CTCF	carries	out	 all	
these	 diverse	 functions	 is	 still	 not	 clear.	 Some	 investigators	 have	 suggested	 that	
CTCF	might	function	through	topological	organization	of	the	genome	by	folding	the	
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genome	 into	 loop	domains,	 in	 that	way	 isolating	 the	 genes	 from	 the	 influence	 of	
neighboring	genes	or	regulatory	sequences.	Additionally,	CTCF	could	be	important	





























study,	which	 shows	 that	CTCF	 is	 not	 absolutely	 required	on	both	 interacting	 loci,	
suggested	that	additional	factors	are	involved	in	these	interactions	(Ling	et	al.,	2006).	
Indeed,	 in	 the	case	of	 two	divergently	 transcribed	MHC	class	 II	genes,	HLA-DRB1 
and	HLA-DQA1,	CTCF	requires	at	least	two	additional	factors	to	mediate	long-range	
interactions	(Majumder	et	al.,	2008).
Another	 interesting	 study	 (Lefevre	 et	 al.,	 2008)	 supports	 a	 model	 in	 which	
transcription-dependent	 chromatin	 remodeling	 leads	 to	 physical	 dislodgement	




cis	 elements	 (Lefevre	 et	 al.,	 2005).	 	 LPS	 stimulation	 triggers	 destabilization	 of	
nucleosomes	and	exposure	of	the	flanking	enhancer	elements,	which	in	turn	allows	
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recruitment	 of	 additional	 factors	 and	 the	 initiation	 of	 non-coding	 RNA	 synthesis.	










with	α-globin-	 like	 proteins	 and	 heme	 groups	 they	 form	 a	 functional	 hemoglobin	
molecule.	Both	α-	and	β-globin	genes	duplicated	several	times,	subsequently	evolved	
independently	 and	 ended	 up	 on	 different	 chromosomes	 in	 birds	 and	 mammals	








LCR,	 a	 dominant	 regulatory	 element	 that	 confers	 position-independent	 and	 copy	
number	dependent	expression	of	linked	transgenes	(Grosveld	et	al.,	1987).	Additional	
Figure	3
Action	 of	 CTCF	 in	 the	 mouse	 Igf2/H19	
locus
On	 the	 maternally	 transmitted	 allele,	
CTCF	binds	to	the	sites	in	the	imprinted	
control	 region	 (ICR)	 and	 prevents	











expression	 but	 did	 not	 alter	 chromatin	 structure	 (Epner	 et	 al.,	 1998).	 Importantly,	
none	of	the	individual	HS	sites	deletions	affected	the	formation	of	the	remaining	sites,	































A.	Schematic	 representation	of	 the	mouse	β-globin	 locus	with	 the	position	of	CTCF	binding	sites,	
which	are	indicated	with	red	ovals.	The	β-globin	genes,	aligned	in	the	order	of	their	developmental	
expression,	are	 indicated	by	black	boxes.	Olfactory	 receptor	genes	(OR)	are	 represented	by	white	
boxes	and	flank	the	locus.	DNAse	I	hypersensitive	sites	(HS)	are	indicated	with	arrows.


















boundary	 definer	 and	 genome	 organizer.	 It	 binds	 to	 DNA	 in	 a	 sequence-specific	
manner,	with	11-zinc-finger	domains.	
A	 first	 attempt	 to	 map	 CTCF	 binding	 sites	 in	 a	 genome-wide	 fashion	 was	
performed	using	ChIP-on-Chip	in	fetal	liver	cells	(Mukhopadhyay	et	al.,	2004).	In	this	
procedure,	 chromatin	 is	 cross-linked,	 sonicated	 and	 protein-DNA	 complexes	 are	
purified	by	immunoprecipitation.		Following	de-crosslinking,	the	associated	proteins	
are	degraded,	and	the	isolated	DNA	is	labelled	and	hybridized	to	microarrays	that	
































dissociates	 from	chromatin	during	prophase,	 in	 a	process	 regulated	by	Aurora	B	
and	 Polo	 kinase,	 whereas	 a	 small	 population,	 located	 preferentially	 at	 pericentric	
heterochromatin,	 remains	 on	 the	 condensed	 chromosomes	 until	 anaphase.	 This	
















sister	 chromatids	 together	 by	 embracing	 the	 two	DNA	duplexes	within	 its	 coiled-
coil	arms,	trapping	sister	DNAs	inside	its	ring	(Gruber	et	al.,	2003).	This	topological	
model	 for	Cohesin	 interaction	with	DNA	 is	 further	 supported	 by	 experiments	with	
circular	DNA	molecules	in	yeast	(Ivanov	and	Nasmyth,	2005)	explaining	how	cleavage	
of	Scc1/Rad21	by	separase	at	the	onset	of		anaphase	opens	the	ring	and	thereby	












DNA	 is	damaged	challenged	 this	opinion	 (Strom	et	al.,	2007;	Strom	and	Sjogren,	
2005).	 In	 this	 process,	 if	 DNA	 is	 damaged	 by	 double-strand	 breaks,	 Cohesin	 is	
loaded	de novo	 to	 the	damaged	DNA	 forming	physical	 connections	between	 the	






Early	 evidence	 that	 the	 sister	 chromatid	 cohesion	 apparatus	 plays	 a	 role	 in	
gene	expression	arose	from	studies	on	gene	silencing	in	yeast	and	on	long-range	
gene	 activation	 in	Drosophila	 (Donze	 et	 al.,	 1999;	Rollins	 et	 al.,	 1999).	 The	 yeast	
data	indicated	that	Cohesin	helps	establish	the	boundaries	that	define	the	silenced	




In	S.cerevisiae,	 the	 silent	 loci	 are	 surrounded	 by	 boundary	 elements	 that	 are	
able	 to	 block	 the	 spread	 of	 the	 silent	 chromatin	 established	 by	 chromatin-bound	
SIR	 (silent	 information	 regulator)	 protein	 complexes.	 Deletion	 of	 the	 boundaries,	
that	surround	silent-mating-type	loci,	leads	to	spreading	of	SIR	complexes	into	the	
neighboring	 regions	 (Donze	et	al.,	1999).	A	genetic	screen	of	 the	 factors	 that	are	
able	to	establish	this	type	of	boundary	revealed	that	some	mutations	of	Smc1	cause	
loss	of	boundary	function	(Donze	et	al.,	1999).	Supporting	this	idea,	the	Scc1/Rad21	








b	 –	 e	 Models	 proposed	 to	 explain	 how	 Cohesin	
interacts	with	DNA








interacts	 with	 each	 other.	 The	 intermolecular	







SIR	 proteins,	 indicating	 that	 Cohesin	 binding	 to	 this	 loci	 dependent	 on	 silencing	
(Chang	et	al.,	2005;	Kobayashi	et	al.,	2004).	The	presence	of	Cohesin	in	rDNA	and	





	 Genome-wide	mapping	 of	 Cohesin	 binding	 sites	 in	 yeast	 revealed	 a	 strong	
correlation	 of	 Cohesin	 binding	 to	 non-transcribed	 spacer	 regions	 between	













However	 this	mechanism	appears	 unlikely	 after	 it	was	 shown	 that	 reduced	 levels	













on	 each	 sister	 chromatid	 to	 come	 together.	However	 it	 appears	 unlikely	 to	 act	 in	












The	 genomic	 location	 of	 Cohesin	 has	 been	 demonstrated	 by	 chromatin-
















regions	 (5’UTRs)	 and	 in	 intronic	 regions.	 The	 prevalence	 of	 Cohesin	 subunits	 at	
5’UTRs	suggests	that	there	is	correlation	between	Cohesin	binding	and	the	presence	
of	a	poised	PolII	at	 the	5’end	of	a	subset	of	genes.	Thus	Cohesin	may	function	 in	







region.	Additionally,	while	Cohesin	 is	present	 in	non-coding	regions	of	 transcribed	
genes	 in	 Drosophila,	 it	 has	 reduced	 binding	 over	 coding	 regions,	 similar	 to	 the	
situation	 in	yeast.	The	mechanism	of	how	Cohesin	 responds	 to	different	states	of	
transcription	has	not	been	determined	(McNairn	and	Gerton,	2008).
It	 is	not	clear	why	 the	distribution	of	Cohesin	binding	sites	differs	so	much	 in	
yeast	and	Drosophila.	It	could	be	that	is	not	particularly	important	for	sister	chromatid	
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structure,	 or	 by	 increasing	 the	binding	affinity	 through	CTCF-Cohesin	 cooperative	
binding	(Gause	et	al.,	2008).
The	 co-localisation	 of	 CTCF	 and	 Cohesin	 raises	 the	 question	 what	 is	 the	




β-globin	 insulator	 (Wendt	 et	 al.,	 2008).	 In	 a	 further	 analysis	 they	 investigated	 the	
effect	of	depletion	either	Rad21	or	CTCF	on	H19	transcript	levels	at	the	endogenous	
H19/Igf2	 locus.	The	transcript	levels	of	H19	where	decreased	while	 Igf2	transcripts	
were	 increased,	mimicking	what	 occurs	when	 the	 insulator	 is	 inactivated	by	DNA	
methylation	on	the	paternal	chromosome	during	imprinting.	The	finding	that	Cohesin	
accumulates	 at	CTCF-binding	 sites	 suggests	 the	 exciting	 possibility	 that	Cohesin	
stabilizes	CTCF-mediated	long-range	interactions.	It	is	possible	that	a	portion	of	the	
available	Cohesin	 is	 diverted	 from	a	 role	 in	 sister	 chromatid	 cohesion	 to	 support	
long-range	interactions.
Although	 the	 data	 above	 strongly	 suggest	 a	 role	 in	 long-range	 interaction,	 it	
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is	 important	 to	determine	how	and	where	Cohesin	subunits	organize	higher-order	








multiple	 HEAT	 repeats,	 which	 are	 related	 to	 Armadillo-like	 repeats	 that	 mediate	
protein-protein	 interactions	 (Neuwald	 and	 Hirano,	 2000).	 In	 addition	 to	 the	 HEAT	
repeats,	the	N-terminus	of	Metazoan	Delangin	contains	a	Heterochromatin	Protein	1	
(HP1)	binding	domain	that	was	shown	to	interact	with	HP1α.	This	interaction	raises	




The	 Figure	 proposes	 that	 the	 CTCF-Cohesin	 complexes	might	 establish	 and	 stabilize	 long-range	






















in	mouse	 is	embryonic	 lethal,	due	 to	developmental	defects,	which	 indicates	 that	
Pds5	has	an	important	role	in	the	process	of	cohesion.
4. Delangin 
Drosophila	 Nipped-B (Delangin	 in	 mammals)	 is	 an	 essential	 gene	 that	 was	
identified	in	a	genetic	screen	for	mutants	interfering	with	long-range	gene	activation	
of	the	cut	and	Ultrabithorax	(Ubx)	homeobox	genes	by	enhancers	positioned	some	

















repeats:	 protein-protein	 interaction	 motifs	 that	 have	 been	 reported	 in	 conserved	
position	 in	Delangin	homologues,	 including	Drosophila Nipped-B,	Saccharomyces 
cerevisiae Scc2,	Schizosaccharomyces pombe Mis4 and	Coprinus cinereus Rad9.	
4.1	Chromosomal	and	DNA	repair	functions	of	Cohesin	and	Delangin		 	 	
	 orthologues	







Studies	 in	S.cerevisie	 and	 chicken	 cells	 gave	 the	 first	 evidence	of	 the	 role	 of	
Cohesin	in	postreplicative	DNA	repair	(Sjogren	and	Nasmyth,	2001;	Sonoda	et	al.,	
2001).		Immunostaining	analysis	of	laser-induced	damage	in	human	cells	and	Chip	
(Chromatin	 immunoprecipitation)	 analysis	 of	 the	 HO-endonuclease-induced	 DSB	





C. cinereus Rad 9 
C.elegans Pqn-85 

















of	 damaged	and	 intact	 sister	 chromatids.	One	elegant	 experiment	 in	S.cerevisiae 
showed	that	Cohesin	is	indeed	needed	at	the	damaged	site	in	G2	to	promote	sister	
chromatid	cohesion.	In	this	experiment	it	was	shown	that	Cohesin	is	newly	recruited	






sites	 can	 establish	 sister	 chromatid	 cohesion.	 This	 fact	 suggests	 that	 function	 of	




damage,	Cohesin	 is	 loaded	at	CARs	but	cannot	mediate	cohesion	 (Lengronne	et	
al.,	2006).	Upon	DSBs,	the	DNA	damage	response	pathway	induces	DSB-proximal	
Cohesin	loading	(Unal	et	al.,	2004).	It	has	been	suggested	that	DSBs	are	cohesive	
through	 the	action	of	 factors	 that	have	different	action	 in	other	phases	of	 the	cell	





of	 DSBs	 on	 one	 chromosome	 is	 sufficient	 to	 induce	de novo	 cohesion	 on	 other	
chromosomes	i.e.	Cohesin	complexes	could	establish	cohesion	on	both	damaged	











from	 humans,	 where	 cells	 derived	 from	 Cornelia	 de	 Lange	 patients,	 who	 have	
a	mutation	 in	Delangin	 gene,	 have	 a	 reduced	 capacity	 to	 tolerate	DNA	damage.	
Exposure	 of	CdLS	 fibroblasts	 and	B-lymphoblastoid	 cells	 to	 the	damaging	 agent	
mitomycin	C	(MMC)	leads	to	increased	number	of	chromosomal	aberrations.	After	




	 Cornelia	 de	 Lange	 syndrome	 (CdLS;	 OMIM	 122470)	 is	 a	 rare	 multisystem	
developmental	disorder	with	characteristic	facial	dysmorphia,	growth	and	cognitive	
retardation,	malformations	of	the	upper	limbs	and	a	variety	of	abnormalities	affecting	




disorders	 that	display	subsets	of	 these	 features.	There	 is	marked	heterogeneity	 in	
the	 phenotype.	 Individuals	 who	 show	 profound	 growth	 and	 neuro-developmental	





for	 autosomal	 dominant	 inheritance:	 in	 others,	 germinal	mosaicism	 (mosaicsm	 in	
which	an	 individual	has	a	subset	of	germline	cells	 carrying	a	mutation	 that	 is	not	
found	in	other	germline	cells)	(Strachan,	2005).
Although	 genetic	 data	 and	 samples	 were	 accumulated	 over	 several	 years,	










Delangin	 mutations	 have	 been	 identified	 in	 about	 half	 of	 the	 CdLS	 patients.	
Recently,	 two	mutations	 in	 the	Smc1L1	 gene	 (Xp11.21)	 were	 identified	 in	 certain	
relatively	mild	cases	of	CdLS	that	lacked	a	Delangin	mutation	(Musio	et	al.,	2006).	
Smc1L1,	which	encodes	 the	Smc1	Cohesin	 subunit,	 is	X-linked,	 and	 the	affected	
individuals	are	male.	This	indicates	that	the	mutations	are	unlikely	to	be	strong	loss-
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are	 located	 in	 the	 five	 candidate	 regions	 identified	 by	 linkage	 exclusion	 (Dorsett,	
2007).	 It	 is	also	likely	that	some	CdLS-causing	mutations	occur	 in	non-transcribed	
regulatory	regions	of	Delangin	gene,	or	have	been	missed	because	the	large	gene	




The	 known	Delangin	 mutations	 indicate	 that	 reduced	 levels	 or	 activity	 of	 the	
encoded	Delangin	protein	cause	CdLS.	Many	Delangin	mutations	predict	a	protein	
truncation,	 although	 it	 is	 currently	 unknown	 whether	 or	 not	 the	 encoded	 mutant	
proteins	are	expressed.	A	deletion	removing	the	Delangin	region	was	seen	in	a	severe	
case	 of	 CdLS,	 supporting	 the	 idea	 that	 loss-of–function	 mutations	 cause	 CdLS.	







An	 intriguing	 finding	 from	molecular	 analysis	 of	Delangin	 mutations	 in	 CdLS	
patients	 is	 that	 a	 central	 conserved	 arginine	 residue	 (R2298)	 in	 one	 of	 the	HEAT	
repeats	 has	 been	 altered	 by	missense	mutations	 in	multiple	 independent	 cases,	
suggesting	that	it	is	a	critical	residue.	Another	important	finding	is	that	with	only	a	few	
exceptions,	the	Delangin	missense	mutations	associated	with	CdLS	affect	residues	
conserved	 in	 Drosophila Nipped-B.	 Thus,	 it	 appears	 likely	 that	 determination	 of	
the	molecular	 function	of	Nipped-B	 in	Drosophila	 and	other	model	organisms	will	
illuminate	the	molecular	etiology	of	CdLS	(Dorsett,	2007).
Evidence	 from	 Drosophila	 favors	 the	 idea	 that	 the	 developmental	 disorders	
in	 CdLS	 are	 caused	 by	 altered	 expression	 of	 genes	 that	 control	 development.	
Although	the	effects	on	sister	chromatid	cohesion	are	seen	in	homozygous	Nipped-









elements	 for	 appropriate	 temporal	 and	 spatial	 expression.	 Many	 of	 those	 could	
explain	some	of	the	developmental	deficits	in	CdLS	(Dorsett,	2007).
The	Drosophila	 data	 also	 suggest	 that	 the	Smc1L1	 is	 associated	with	milder	
forms	of	CdLS	 likely	cause	alterations	 in	gene	expression.	A	null	allele	of	Smc1L1	
in	Drosophila	 dominantly	 increases	cut	 gene	expression	 (Dorsett	 et	 al.,	 2005),	 as	
does	RNAi	knockdown	of		the	Stromalin	and	Rad21	Cohesin	subunit	(Rollins	et	al.,	
2004).	These	effects	are	opposite	to	those	of	Nipped-B	mutations,	and	thus	it	might	




have	 similar,	 but	 not	 identical,	 effects	 on	 development	 as	 their	 under	 expression	
(Dorsett,	2007).



























model	 is	 essential	 to	 identify	 target	genes	 relevant	 to	 specific	CdLS	birth	defects	
(Dorsett,	2007).
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5. Role of Ldb1 in long-range gene activation
Existing	evidence	indicates	that	most	transcriptional	activator	proteins	recruit	the	
basal	 transcriptional	machinery	 and	 increases	 its	 binding	 to	 a	promoter	 (Ptashne	
and	Gann,	1997).	Often,	an	activator	binds	to	a	sequence	located	many	kilobases	
away	from	the	promoters	it	activates.	In	these	cases,	the	local	concentration	of	the	
activator	 relative	 to	 the	 promoter	 it	 activates	 is	 not	 higher	 than	 its	 concentration	

















the	promoter	contains	many	enhancers	 that	activate	cut	 in	specific	 tissues	during	
embryogenesis	and	larval	development	(Jack	and	DeLotto,	1995).	In	addition	to	tissue-






model	 for	 long-range	enhancer-promoter	 interactions	was	proposed	to	explain	the	
properties	 of	Drosophila Chip	protein	 (Dorsett,	 1999;	Gause	 et	 al.,	 2001).	 Recent	






























is	 required	 for	 their	 high-level	 expression	 in	 erythroid	 cells	 (Stamatoyannopoulos,	
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Erythrocytes are derived from the haematopoietic stem cell (HSC)
(Durand and Dzierzak, 2005). From approximately E8.5 to
E10.5 in the mouse, definitive HSCs are derived from the
aorta–gonado–mesonephros region (AGM) (Medvinsky and
Dzierzak, 1996; Yoder et al., 1997; de Bruijn et al., 2000; Cumano
et al., 2001). Recently the placenta has been identified as a further
source of adult HSCs (Gekas et al., 2005; Ottersbach and Dzierzak,
2005). At E11 the mouse fetal liver becomes the main organ of
haematopoiesis, later replaced by the bone marrow.
HSC differentiation involves coordinated changes in
transcription, often by functionally conserved genes such as
Gata2, Tal1, Lmo2, Gata1 and Runx1/Aml1 (Cantor and Orkin,
2001).
Often the binding sites for transcription factor complexes are
located at great distance from the genes that they control. In the
human and mouse �-globin locus, the interacting binding sites and
genes are spread over a distance of 100 kb. A three-dimensional
structure resulting from long-range interactions, the Active
Chromatin Hub (ACH), has recently been demonstrated (Tolhuis et
al., 2002; Palstra et al., 2003; Patrinos et al., 2004). We anticipate
that (novel) classes of proteins will mediate such 3D interactions of
distal regulatory elements. An example of such a protein is
Chip/Ldb1 (Morcillo et al., 1997), a protein that can interact with
the insulator protein Su(Hw) (Torigoi et al., 2000). Initially isolated
in a screen for proteins that bind LIM domains (Agulnick et al.,
1996), orthologues of Ldb1 have now been identified in a range of
other species. Ldb1 is a ubiquitously expressed nuclear protein that
does not bind DNA but appears to participate in transcriptional
control by acting as a co-factor for other proteins. It is part of a
protein complex in murine erythroid cells composed of the
haematopoietic transcription factors Lmo2, Tal1, Gata1 and E2A
(Tcfe2a – Mouse Genome Informatics) (Wadman et al., 1997)
binding to a GATA-E box motif. This complex binds to the locus
control region and �-globin promoter of murine erythroleukemic
(MEL, C88) cells (Brand et al., 2004), to the erythroid specific
glycophorin A (Gypa) promoter (Lahlil et al., 2004), and to
multiple sites in the �-globin locus during erythroid differentiation
(Anguita et al., 2004).
Consistent with its interaction with a broad range of transcription
factors involved in development, the Ldb1 knockout mouse dies
between E9.5 and E10.5 from a series of developmental defects,
including absence of haematopoieisis (Mukhopadhyay et al., 2003)
(A.H., unpublished). The latter partly resembles the knockout
phenotypes of the haematopoietic transcription factors Lmo2 and
Tal1 (Warren et al., 1994; Robb et al., 1995; Shivdasani et al.,
1995).
In order to understand the role of Ldb1 in erythroid transcriptional
interactions, we performed a biochemical screen to identify its
binding partners. Using in vivo biotinylation (de Boer et al., 2003;
Rodriguez et al., 2005) we describe a number of novel partners. We
show that Ldb1 forms complexes that change composition during
C88 cell differentiation, and that these complexes are bound to the
target genes in vivo. We show that Ldb1 and its binding partners are
co-expressed at early stages of development of the murine
haematopoietic system, and that the novel erythroid binding partners
are required for development of the definitive but not the primitive
haematopoetic system of zebrafish embryos.
MATERIALS AND METHODS
Ldb1 cDNA and bio-Ldb1 construct cloning
Ldb1 cDNA was cloned from D14.5 fetal liver RNA (Trizol, Life
Technologies) by RT-PCR (SuperScriptII Reverse transcriptase, Invitrogen;
Pfu Polymerase, Promega) into the EcoRI site of pBluescript (pBS)
(construct AH-3).
ATG-less Ldb1 cDNA was amplified and cloned between the BamHI and
NotI sites of pBS. The bio-tag was cloned directly in front of the ATG-less
cDNA. Tagged cDNA was isolated as a XhoI–NotI fragment and cloned into
the SalI and NotI sites of pEV-Neo (de Boer et al., 2003) to give construct
pEV-Neo-bio-Ldb1.
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MEL cell transfection and culture
C88 cells were cultured and induced for differentiation with DMSO as
previously described (Antoniou, 1991). C88BirA cells (Rodriguez et al.,
2005) were transfected by electroporation with ScaI-linearised pEV-Neo-
bioLdb1, cultured in 96-well plates containing medium with 1 �g/ml
puromycin and 0.8 mg/ml neomycin to select single clones (de Boer et al.,
2003; Rodriguez et al., 2005).
Nuclear extract preparation
Small-scale nuclear extract preparation of C88 cell cultures (30-50 ml) and
nuclear extracts of larger cultures (5.5-9 L) were prepared as described by
de Boer et al. (de Boer et al., 2003).
Strepatavidin pulldown and mass spectrometry
Strepatavidin-coated Dynabeads M-280 (Dynal) were blocked for 1 hour
with chicken serum albumin/PBS (200 ng/�l). The salt and detergent
concentrations of nuclear extract samples of 5-6 mg from induced
C88BirA/bio-Ldb1 cells or 15 mg from noninduced C88BirA/bio-
Ldb1 cells were adjusted to 200 mM KCl and 0.3% NP40 with 10 mM
KCl buffer (10 mM KCl, 10 mM HEPES-KOH, 1.5 mM MgCl2, 25%
glycerol, 0.75% NP40, 2 mM PMSF) prior to overnight incubation with
blocked beads at 4°C. The beads were washed for 5 minutes six times in
washing solution (150/200 mM KCl, 10 mM HEPES-KOH pH 7.9, 1.5
mM MgCl2, 0.2 mM EDTA, 0.3% NP40, 0.2 mM PMSF) at room
temperature. Pulled down proteins were processed and analysed by
mass spectrometry (LC-MSMS, MS) as described (Rodriguez et al.,
2005).
Immunoprecipitations and western blot analysis
Immunoprecipitations and western blot analysis were performed as
previously described (Rodriguez et al., 2005). Bio-Ldb1 was detected using
a 1/10,000 dilution of Streptavidin-Horseraddish Peroxidase (HRP)
conjugate (NEN).
Antibodies
Monoclonal rat antibodies against Mtgr1 and Lyl1 were produced by Absea.
The antibody against E2-2 was obtained from Abcam (ab2233), and all
others were from Santa Cruz Biotechnology: �-Ldb1 (sc-11198), �-Lmo2
(sc-10499), �-Lmo4 (sc-11121, sc-22833), �-Eto-2 (sc-9741), �-Runx1 (sc-
8563), �-Cdk9 (sc-484), �-HEB (sc-357), �-E2A (sc-349), �-Gata1-N6 (sc-
265), �-HDAC1 (sc-7872), �-NMP 238 (sc-15259). The antibody against
NMP 238 was used as a loading control for the IP experiments, because it
showed no change after induction.
Chromatin immunoprecipitations
Fixation, lysis of cells and sonication of chromatin were performed
as previously described (Rodriguez et al., 2005). Primers for real-
time PCR were as described (Rodriguez et al., 2005). Primers
for the Gata1 hypersensitive site (HS) and negative control sequences
were:
Gata1 HS-3.5 Reverse primer: 5�-CCGGGTTGAAGCGTCTTCT-3�
Gata1 HS-3.5 Forward primer: 5�-TCAGGGAAGGATCCAAGGAA-3�
Gata1 Negrev: 5�-TGCCGCTTGCCTTTGTAAG-3�
Gata1 Negfor: 5�-CACTAGCAGCTGGGTGGGTTA-3�
Zebrafish maintenance and morpholino injections
Wild-type zebrafish were kept and staged according to Westerfield
(Westerfield, 1993). ATG morpholinos (MO) (Gene-Tools) and
corresponding mismatch MOs were derived from the genebank cDNA of
ldb1 (NM_131313, 5�-GCCCACGTCTCGGTCCAGCATGGTG-3�), tcf4
(NM_131259, 5�-AGCTGCGGCATTTTTCCCGAGGAGC-3�), cdk9
(BC055634, 5�-CGACGCCATCGTAGTATTTGGACAT-3�, control
mismatch MO 5�-CGAgGaCATCGTAcTATTTaGAgAT-3�), lmo4
(NM_177984, 5�-AGCTTTCCACACGACTGTTCACCAT-3�, control
mismatch MO 5�-AGgTTTgCACACcACTGTTgACgAT-3�), mtgr1
(XM_695328 5�-CTCTTAAAAGCGTGAAAGACCGCAT-3�, control
mismatch MO 5�-CTgTTAAAAcCGTcAAAGAgCGgAT-3�), eto-2
(EST AF164710 5�-AACATGACGGTTGGAACTCTGGTT-3�, control
mismatch MO 5�-AAgATcACGGTTcGAACTgTGcTT-3�).
All MOs were dissolved in water to a concentration of 1 mM and injected
at three doses (0.1 nl, 0.5 nl and 1.2 nl) into zebrafish embryos at the two- to
eight-cell stage. As an injection control, rhodamin-dextrane or phenol red
were added to a concentration of 10% vol/vol before use.
Whole mount in situ hybridisation
Digoxigenin-UTP (Roche) labelled antisense and sense RNA probes
against the zebrafish orthologues of hemoglobin beta embryonic-1 (�E1)
(Quinkertz et al., 1999) and runx1 (M. Gering) were synthesized from
linearised plasmids using T3 and T7 RNA polymerases. In situ
hybridisation was performed as described previously (Jowett and Yan,
1996). To remove pigmentation, embryos older than 32 hours
postfertilisation (hpf) were treated with 5% H2O2/PBS for 2-3 hours prior
to in situ hybridisation.
Probes were detected by incubation with alkaline phosphatase coupled
anti-Digoxigenin antibody (Roche) and colour reaction with Fast Red
(Roche) for �E1 and BM Purple (Roche) for runx1.
Immunohistochemistry
E9.5 FVB mouse embryos were fixed in 2% paraformaldehyde/PBS for 2
hours at room temperature. After overnight equilibration in 20%
Sucrose/PBS at 4°C, embryos were orientated and quick frozen in Tissue
Tek (Sakura Finetek).
Immunohistochemistry was essentially carried out as previously
described (de Bruijn et al., 2002). All animal experiments were carried out
according to the Dutch Welfare of Animals Act.
RESULTS
Generation of bio-Ldb1 cells
In order to identify Ldb1 interacting partners, C88BirA MEL cells
expressing the Escherichia coli BirA protein-biotin ligase (de Boer
et al., 2003) were stably transfected with pEV-Neo-bio-Ldb1
(Fig. 1A).
A total of 16 C88BIR/bioLdb1 clones were isolated and induced
to differentiate with DMSO. Nuclear extracts were tested for
presence of the fusion protein using an �-Ldb1 antibody and
streptavidin-HRP (Fig. 1B). Clone #3F4 was chosen because it
expresses low levels of bio-Ldb1 (Fig. 1C) in the uninduced state.
This allowed us to compare Ldb1 complexes before and after
terminal differentiation.
Identification of Ldb1 interaction partners
Nuclear extracts prepared from noninduced and induced #3F4 cells
and untransfected C88 cells were incubated with streptavidin-coated
paramagnetic beads, and separated by polyacrylamide gel
electrophoresis (PAGE) (de Boer et al., 2003; Rodriguez et al., 2005)
(Fig. 1D). Proteins were trypsin digested, eluted and analysed by
mass spectrometry (LC-MSMS). Table 1 shows the pulled down
proteins when washed with 150 mM and 200 mM KCl. The pattern
of background proteins was similar to that observed for Gata1 (de
Boer et al., 2003; Rodriguez et al., 2005) and other transcription
factors (H. Braun, J. Demmers and J. Philipsen, personal
communication).
The screen was validated by the fact that known Ldb1 partners
(Lmo2, Tal1, Gata1 and E2A) (Wadman et al., 1997) were readily
identified. We also found three proteins of the Ssdp family, members
of which interact with Ldb1 in HeLa cells and in Drososphila (Chen
et al., 2002; van Meyel et al., 2003; Nishioka et al., 2005). These
Ssdp interactions were not analysed further. In addition, a number
of novel (potential) interaction partners of different functional
classes were found, including transcription (co-)factors, cell-cycle
proteins, chromatin remodelling and DNA repair proteins. Some of
the previously identified binding partners of Ldb1 (Tal1, E2A), the
basic helix-loop-helix (bHLH) proteins HEB (Tcf12 – Mouse
Genome Informatics), E2-2 (Tcf4 – Mouse Genome Informatics),












Lyl1 and the novel interacting protein Eto-2 (Cbfa2t3h – Mouse
Genome Informatics) were detected in all three analyses. Eto-2, an
orthologue of the D. melanogaster gene nervy, was the most
abundant protein in two of the three LC-MSMS outputs. Mtgr1
(Cbfa2t2 – Mouse Genome Informatics), another member of the
ETO protein family, was also identified by MS analysis of
noninduced and induced cell extracts. The known partner Lmo2 was
present in extracts from noninduced and induced cells (Fig. 2),
whereas Lmo4, Gata1 and Runx1 were present in the MS analyses
of induced cells only, although it should be noted that Gata1 may
have been absent due to the fact that only very few Gata1 peptides
are detectable in our MS analyses (Rodriguez et al., 2005). In
contrast to the proteins mentioned above, the cell-cycle protein Cdk9
was only found in nuclear extracts of noninduced cells. Proteins of
different chromatin remodelling complexes were also identified only
in induced cell extracts, for example Hdac1 (see Fig. S1B in the
supplementary material), but these have as yet not been investigated
in detail.
Western blots of equal amounts of nuclear extracts of noninduced
and induced C88 cells showed that the levels of all binding partners
except for the newly identified interacting proteins Eto-2, Cdk9 and
Lmo4, did not change significantly (Fig. 2, input lanes) in normal
untransfected cells and bio-Ldb1 cells. Levels of Lmo4 and Cdk9
increased with induction, whereas there was considerably less Eto-
2 in induced extracts (Fig. 2A, input Lmo4, Cdk9 and Eto-2 panels).
Interestingly, the much less abundant 55 kD isoform of Cdk9 (Shore
et al., 2003) is upregulated with induction, while the 41 kD isoform
of Cdk9 decreases in untransfected MEL cells, and is present at the
same levels in noninduced and induced bio-Ldb1 extracts (Fig. 2,
input Cdk9 panels); this phenomenon is also seen in differentiating
macrophages (Liu and Herrmann, 2005).
Identification of different complexes
To confirm the interactions found in the MS analysis,
immunoprecipitations of equal amounts of nuclear extracts from
induced and noninduced C88 cells (Fig. 2) were performed with an
�-Ldb1 antibody. Immunoprecipitations carried out on normal C88
cells and bio-Ldb1 transfected cells showed essentially the same
results. The �-Ldb1 antibody depleted the extracts of noninduced
cells almost completely of Ldb1 (Fig. 2A,B). Lmo2, Tal1, the two
E2A isoforms E12 and E47, HEB and Gata1, precipitated equally
with Ldb1 before and after induction (not shown). The only
difference we observed between the bio-Ldb1 transfected cells and
untransfected cells was a small change in the ratio of expression of
E12 and E47 (Fig. 2A,B, E2A panels). Consistent with its lower
level in induced cell extracts, less Eto-2 precipitated with Ldb1 from
induced cell extracts compared with that of noninduced cells (Fig.
2A,B, Eto-2 panels). Mtgr1, the other identified Eto-family member,
was also enriched to a lesser extent in induced cells (Fig. 2A,B,
Mtgr1 panels). As expected, more Lmo4 precipitated with Ldb1 in
induced cells compared with noninduced cells (Fig. 2A,B, Lmo4
panels), whereas the amount of coprecipitated Lmo2 did not change
(not shown). These results suggest that the newly identified partner
Lmo4 may play a more important role at later stages of erythroid
differentiation. Most notably, the two isoforms of Cdk9
immunoprecipitated with Ldb1 only in noninduced cells (Fig. 2A,B,
Cdk9 panels). As Cdk9 is involved in cell-cycle progression
(Bettencourt-Dias et al., 2004), its interaction with Ldb1 in
noninduced, proliferating C88 cells only, may link the complex
containing Ldb1 and Cdk9 to the maintenance of the proliferative
state. Although their level is unchanged, there was less
coprecipitation of E2-2 and Lyl1 with either �-Ldb1 (Fig. 2A,B) or
�-Eto-2 (not shown) in induced cells.
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Fig. 1. Ldb1 biotinylation and streptavidin pulldown. (A) Schematic representation of bio-Ldb1. The 23 amino acid sequence recognised by
BirA and a triple haemagglutinin tag are fused in tandem to the amino-terminal end of the ATG-less Ldb-cDNA. (B) Expression of Ldb1 and bio-
Ldb1 in nuclear extracts of induced C88BirA/bio-Ldb1, C88-/BirA and C88–/– cells. Eight of 16 transfectants are shown. Three clones (lanes 3-5) did
not express bio-Ldb1, lane 9 not loaded. Clone #3F4 was chosen for further experiments. Lanes on the right are C88-/BirA and C88–/– controls.
(C) Ldb1 and bio-Ldb1 expression in equal amounts (see Coomassie stained gel) of nuclear extracts of noninduced (–) and induced (+) #3F4 cells.
Expression of endogenous Ldb1 is reduced in induced cells. (D) PAGE of proteins bound to bio-Ldb1. Pulldowns of noninduced and induced cell










In order to gain a better understanding of some of the Ldb1-
containing complexes, and to determine whether Ldb1 binding
partners bind to Ldb1 in the absence of Eto-2 and vice versa, we
performed sequential immunoprecipitation experiments. We first
depleted nuclear extracts of either Ldb1 or Eto-2 with their
respective antibodies, and then incubated the supernatants with �-
Eto-2 and �-Ldb1 respectively (Fig. 3 and see Fig. 1A in the
supplementary material). Immunoprecipitations were then
analysed for Ldb1 interacting proteins identified and validated in
the single immunoprecipitation experiments (Fig. 3). It should be
noted that we have not set out to characterise all the possible
complexes that may be formed by every single Ldb1 interacting
partner identified in the MS analysis, a task which is outside the
scope of this paper.
As noted above, the �-Ldb1 antibody (almost) completely
depletes Ldb1 protein from the extract (Figs 2, 3, Ldb1 panels). A
precipitation with �-Eto-2 antibody brings down high amounts of
Ldb1, indicating that a high proportion of complexes contains both
Ldb1 and Eto-2. However, �-Eto-2 did not deplete the extract of
Ldb1 protein, as more Ldb1 protein is precipitated with �-Ldb1
from the �-Eto-2 treated supernatant (Fig. 3, Ldb1 panels).
Conversely, precipitation of Ldb1 with �-Ldb1 antibody brings
down large amounts of Eto-2 (Figs 2, 3, Eto-2 panels) but does not
deplete Eto-2 completely from the extract, as there is more Eto-2 left
in the supernatant (Fig. 3, Eto-2 panel). Thus, there are probably at
least three complexes, one containing both Eto-2 and Ldb1, one that
contains Ldb1 but not Eto-2, and one that contains Eto-2 but not
Ldb1 (Fig. 3B).
To investigate the binding behaviour of Cdk9, the only protein that
does not interact with Ldb1 upon induction of differentiation, we
tested the sequential immunoprecipitations for its presence. �-Ldb1
antibody precipitated Cdk9 with a substantial amount left in the
supernatant, which was not precipitable by �-Eto-2 antibody (Fig.
3, Cdk9 panel). In reverse, incubation of nuclear extracts with �-Eto-
2 antibody also precipitated Cdk9 only partially, the remainder also
not being bound to Ldb1 (Fig. 3, Cdk9 panel). We suggest that Cdk9
requires both Ldb1 and Eto-2 for its interaction with either of the two
proteins. E2-2 and Lyl1 exhibited similar interaction behaviour (Fig.
3), with the exception that Lyl1 is also bound to Ldb1 alone (Fig.
3B).
To test whether the Ldb1-Lmo2 interaction requires Eto-2, we
first depleted Eto-2 followed by Ldb1 immunoprecipitation and
testing for Lmo2 (Fig. 3, Lmo2 panels). �-Eto-2 brought down only
some Lmo2. As all of Lmo2 is in complex with Ldb1 (Fig. 3), we
conclude that there is a complex containing Lmo2-Ldb1-Eto-2, and
that the remaining Lmo2 left in the supernatant after Eto-2 depletion
is bound to Ldb1, but not Eto-2. Lmo4 behaves similarly but shows
an important quantitative difference. There is little Lmo4 before
differentiation, but this increases several fold after induction of
differentiation (Fig. 2).
The two isoforms of E2A show a different binding behaviour. Both
the larger E47 and smaller E12 isoforms are precipitated equally by
Ldb1, albeit incompletely. The remaining E47, but not E12, is bound
by Eto-2 (Fig. 3 and see Fig. S1A in the supplementary material; E2A
panels). Conversely, �-Eto-2 completely depletes the extracts of the
E47 isoform but binds only some E12 (Fig. 3, E2A panel). Some of
this remaining E12 is precipitable by Ldb1. Taking into account the
Ldb-1/E2A data from above, this indicates the presence of a complex
containing Ldb1/Eto-2/E47/E12, two further complexes composed
of at least Eto-2/E47 or Ldb1/E12, and ‘free’ E12 that can participate
in other complex formation.
Mtgr1 was the second member of the Eto family identified in our
MS analysis. �-Ldb1 antibody precipitates some Mtgr1, but not
all, with a substantial amount left in the supernatant that is all
precipitated with an �-Eto-2 antibody (Fig. 3, Mtgr1 panel and see
Fig. S1A in the supplementary material). Precipitation with �-Eto-
2 antibody, however, completely depletes Mtgr1 from the nuclear
extracts, indicating that all Mtgr1 is complexed with Eto-2 (Fig. 3
and see Fig. S1A in the supplementary material; Mtgr1 panels). We
conclude that there are at least two complexes containing Mtgr1: one
complex containing Mtgr1/Eto-2/Ldb1, and that the Mtgr1/Ldb1
interaction requires Eto-2; a further complex containing Mtgr1/Eto-
2, but not Ldb1.
Tal1 also forms several complexes, which contain either Ldb1
and/or Eto-2. �-Ldb1 antibody precipitates most, but not all Tal1
from the nuclear extract, part of the remaining Tal1 is pulled down
with Eto-2 (Fig. 3, Tal1 panel). Testing first with �-Eto-2 shows that
Eto-2 brings down some but not all Tal1; some is precipitable with
an �-Ldb1 antibody (Fig. 3, Tal1 panel). This indicates that there are
at least four Tal1-containing complexes: Eto-2/Tal1/Ldb1,
Ldb1/Tal1, Eto-2/Tal1 and ‘free’ Tal1.
HEB also forms complexes that contain either Ldb1 and/or Eto-
2. Both �-Ldb1 and �-Eto-2 precipitate large amounts of HEB
indicating that HEB forms complexes with Ldb1 or Eto-2, and
probably a complex containing all three of these proteins. A second
precipitation with either �-Eto-2 or �-Ldb1 precipitates more HEB,
although small amounts remain in the supernatant after this second
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Table 1. Proteins identified by LC-MSMS in bio-Ldb1 pulldown
experiments
Non-induced Induced 1 Induced 2
Proteins pulled down C88/BirA LS LS HS
Transcription factors
LIM only proteins
Lmo2 – + – +
Lmo4 – – + +
Zinc finger proteins
Gata1 – – + +
Basic helix-loop-helix
Tal1 – + + +
E2A – + + +
Lyl1 – + + +
HEB – + + +
E2-2 – + + +
ETO-family
Eto-2 – + + +
Mtgr1 – + - +
Runt domain
Runx1 – – + +
Ssdp
Ssdp2 – + + +
Ssdp3 – + + +
RIKENcDNA1210001E11 – + + +
(Ssdp4)
Cell-cycle proteins/kinase
Cdk9 – + – –
The lower amount of identified proteins and their corresponding peptides in the
lower stringency pulldown experiment of induced cells (induced 1) is due to the
lower amount of input for the LC-MSMS analysis.












immunoprecipitation (Fig. 3, HEB panel). Therefore, HEB forms at
least three complexes: HEB/Ldb1, HEB/Eto-2 and ‘free’ HEB.
When an �-HEB immunoprecipitation is carried out, it does
precipitate all the partners, including Lyl1, Cdk9 and E2-2,
suggesting that it is part of a large Ldb1/Eto-2 complex (Fig. 3B), or
perhaps a smaller one containing Ldb1 and Eto-2.
Finally, Gata1, a transcription factor known to participate in a
multitude of complexes (Rodriguez et al., 2005), also forms separate
complexes with either Eto-2 or Ldb1. Treatment of extracts with �-
Ldb1 antibody brings down a small part of Gata1. Further
precipitation with �-Eto-2 provides evidence of an Eto-2-Gata1
interaction separate from Ldb1 (Fig. 3, Gata1 panel, and see Fig.
S1A in the supplementary material). In reverse, �-Eto-2 antibody
indeed precipitates part of Gata1. Very little Gata1 is then
precipitable with an �-Ldb1 antibody, indicating that possibly most
of the Eto-2/Gata1 complex also contains Ldb1 (Fig. 3, Gata1
panel). We conclude that Gata1 forms at least four complexes:
Gata1/Ldb1, Gata1/Eto-2, Gata1/Ldb1/Eto-2 and ‘free’ Gata1,
which is known to participate in other complexes.
Single immunoprecipitations using antibodies for the Ldb1
interacting proteins confirmed all the pairwise interactions described
above (not shown).
Although it is difficult to distinguish the complexes from each
other, the data strongly suggest that there are several subcomplexes
formed by Ldb1 and its interaction partners that can form larger,
functional complexes (possibly via the homodimerisation of Ldb1).
We can distinguish two large subcomplexes with either Ldb1 or Eto-
2 and one large complex containing both Ldb1 and Eto-2 (Fig. 3B
and Fig. 7). Upon differentiation, association with Cdk9 is lost and
the level of Eto-2 is substantially decreased, whereas the amount
of Lmo4 is increased several fold. The reduction in association
between Ldb1 and Eto-2 is also reflected in the reduced
coimmunoprecipitation of E2-2 and Lyl1 with �-Ldb1 and �-Eto-2
in induced cells. In addition, these complexes appear to interact with
Runx1, but we have as yet not been able to characterise this
interaction due to the poor quality of the available antibody.
Chromatin immunoprecipitations
To confirm that Eto-2 and Ldb1 are bound to chromatin at specific
regulatory sites, we carried out chromatin immunoprecipitations
using a number of erythroid genes: Gata1,Gypa,Myb,Myc and Eklf
(Klf1 – Mouse Genome Informatics), for which the binding of Gata1
complexes is known (Rodriguez et al., 2005). Among the Gata1
gene regulatory regions, the HS-3.5 is known to bind the
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Fig. 2. Analysis of Ldb1 interacting protein complexes. Protein levels of Eto-2, Cdk9 and Lmo4 change with induction of C88 cell
differentiation. Western blot analysis of noninduced (Unind.) and induced (Ind.) C88 cells containing bio-Ldb1 (A) or untransfected C88 cell nuclear
extracts (B). Input lanes indicate levels of tested proteins in untreated nuclear extracts diluted to the same concentration as in the
immunoprecipitation experiments. Proteins immunoprecipitating with Ldb1 (IP lane) and supernatant (Sup) are shown and labelled accordingly. The













Gata1/Tal1/Ldb1 complex, whereas the DNaseI hypersensitive site
in the gene (Gata1 IE) does not (Guyot et al., 2004). The GATA-E
box sites in the Gypa and Eklf promoters are also known targets of
Gata1/Ldb1 (Lahlil et al., 2004; Rodriguez et al., 2005). In contrast,
the Myb and Myc genes bind a Gata1/Gfi1b complex (Rodriguez et
al., 2005). In all cases we find an enrichment for Gata1 (as expected)
when compared with non GATA site negative control fragments (not
shown) (Rodriguez et al., 2005). In contrast, Eto-2 and Ldb1 were
bound to Gata1, Eklf andGypa (Fig. 4), but not to Myc andMyb (not
shown). The ratio of Eto-2/Ldb1 binding to the three elements,
decreases during differentiation in C88 cells (Fig. 4) in accordance
with the fact that there is less Ldb1/Eto-2 complex (see Fig. 2).
Gata1, glycophorin A and Eklf proteins are expressed late in
erythroid differentiation [the –3.5 HS of the Gata1 gene also
regulates Gata1 expression in megakaryocytic cells (McDevitt et
al., 1997; Onodera et al., 1997)], whereas Myc and Myb are
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Fig. 3. Sequential immunoprecipitations to investigate Ldb1- and Eto-2-containing complexes. (A) Nuclear extracts of noninduced normal
C88 cells were first depleted of either Ldb1 or Eto-2 with their respective antibodies. The supernatants were then incubated with �-Eto-2 or �-
Ldb1, respectively. The second supernatant was also loaded to determine which proteins do not interact with either Eto-2 or Ldb1. IgG lanes are
control immunoprecipitations carried out with a nonspecific, isotype-matched antibody. (B) Scheme of interacting factors from IP experiments in A
(see also Fig. S1A in the supplementary material). Each new line represents the analysis of an additional three transcription factors.
Fig. 4. ChIP of Ldb1 and Eto-2. (Top) The boxes
indicate the localisation of the upstream HS in the
Eklf, Gata1 and Gypa promoters that contain
Gata-1/Tal1 binding sites and negative controls not
containing such sites. Bar graphs show the relative
enrichment of sequences immunoprecipitated by
Eto-2 (red), Ldb1 (yellow) and the IgG control
(blue) in noninduced (middle row) and induced
(bottom row) C88 cells. All values were normalised












downregulated. The decrease of Eto-2 levels in late erythroid
cells suggests that Eto-2 adds a repressive function to the
Gata1/Tal1/Ldb1 complex to keep late erythroid genes off early
during differentiation. In contrast, Eto-2 is not essential for Gfi1b
repressed genes such as Myb and Myc expressed at early stages
(Rodriguez et al., 2005).
Eto-2, Cdk9 and Lmo4 are required for definitive
haematopoiesis in a zebrafish model system
Ldb1 and its constitutive binding partners Lmo2 and Tal1 are
essential for embryonic blood formation (Warren et al., 1994; Robb
et al., 1995; Shivdasani, 1995). We next asked whether the newly
identified Ldb1 interacting partners E2A, Cdk9, Eto-2, Lmo4 and
Mtgr1 are required for haematopoietic development. As the genetic
regulation of embryonic and definitive haematopoiesis is highly
conserved between zebrafish and mammals, we tested the role of
these proteins by MO-mediated inhibition of mRNA translation in
zebrafish embryos (Nasevicius and Ekker, 2000). In zebrafish,
primitive erythrocytes expressing embryonic haemoglobin derive
from the intra-embryonic intermediate cell mass (ICM) and start
circulating at 24 hpf. Shortly thereafter, with development of the
definitive haematopoietic system, a ventrally located flk1-positive
subpopulation of the dorsal aorta precursors starts to express runx1.
runx1 is also expressed in primitive erythrocytes, the olfactory
epithelium, Rohon-Beard neurons (Kalev-Zylinska et al., 2002) and
the anterior paraxial mesoderm.
ATG-MOs and mutated MOs targeted against the zebrafish
orthologues of Cdk9, Eto-2, Lmo4,Mtgr1 and Ldb1were injected at
three increasing doses into one- to eight-cell stage embryos. To test
the effects of these MOs on the embryonic and definitive
haematopoeitic system, we analysed embryos after onset of blood
circulation by in situ hybridisation with probes against embryonic
�E1 and runx1, respectively (Fig. 5).
Ldb1-MO-injected embryos displayed variable phenotypes at all
doses, including deformation of the body axis, dysmorphic somites,
abnormal tail morphology, haematopoietic defects resembling that of
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Fig. 5. Analysis of zebrafish embryos after MO injections. The developmental stage of each embryo is in the bottom left corner; the targeted
gene is indicated in the top left corner. All pictures were taken at the same magnification. (A) Noninjected wild-type (wt) control embryos stained
for �E1- (zE1b-globin, left column) and runx1-mRNAs (right column). The ICM, dorsal aorta (DA), primitive erythrocytes (Pr.Ery.), anterior paraxial
mesoderm (APM) and olfactory epithelium (OE) are indicated. The �E1signal is red, runx1 signal is blue. Treated embryos were injected with 1 pmol
eto-2-MO (32 hpf), 1 pmol cdk9-MO (28 hpf),1 pmol lmo4-MO (30 hpf), or with 0.5 pmol of the control tcf4-MO (30 hpf). (B) The reduction of
runx1 expression in the dorsal aorta region resulting from injection with the MOs directed against eto-2 (n=23/27), cdk9 (n=33/56) and lmo4
(n=36/54) was still observable after 2 days. Embryos injected with the mtgr1-MO were analysed at 38 hpf and showed only a slight effect on the













the mouse (A.H., unpublished) and necrosis in the brain (not shown).
The severity of defects increased with increasing dose of injected
Ldb1-MO. As a negative control, we used mutated ATG-MOs and an
MO targeted against tcf4, the zebrafish orthologue of Tcf7/2. The
latter is not expressed in haematopoietic tissues and, when deleted,
has a specific effect in the intestinal epithelium of the mouse (Korinek
et al., 1998). As expected, no effects of the mutated ATG-MOs (not
shown) or tcf4-MO on the haematopoietic system were observed in
the injected zebrafish at any dose. Embryos injected with the highest
dose of tcf4-MO displayed some tail abnormalities.
The cdk9-MO had no effect on �E1 expression or expression of
runx1 in the primitive erythrocytes located in the posterior ICM, the
olfactory epithelium and the anterior paraxial mesoderm. However,
they had a severe effect on definitive erythropoiesis. A 0.5-pmol
dose of cdk9-MO showed a clear reduction of runx1 signal in the
dorsal aorta region (n=10/18), which decreased further in embryos
injected with 1 pmol (n=8/10). Surprisingly the effect appears to be
specific to the haematopoietic system, although Cdk9 is expressed
in many tissues (Bagella et al., 1998).
Embryos injected with the eto-2-MOs had a similar phenotype.
The reduction of runx1 expression in embryos injected with 0.5
pmol (n=13/16) and 1 pmol of eto-2-MO (n=5/7) was more severe
compared with the cdk9-MO: runx1 in the dorsal aorta was either
almost or completely abolished. Embryonic �E1 expression was
normal in all eto-2-MO-injected embryos; however, some primitive
erythrocytes in the caudal region were located laterally to the
midline as opposed to their location in wild-type embryos. This is
similar to the effect observed when sonic hedgehog signalling is
inhibited (Gering and Patient, 2005), suggesting that eto-2 may play
a role in the response to extracellullar signals. Injection of 1-2 pmol
of the mtgr1-MO did not affect embryonic haematopoiesis. Some
reduction of runx1 expression in dorsal aorta precursor cells was
observed at 38 hpf (n=5/25; Fig. 5B).
Embryos treated with the lmo4-MO were comparable to
knockdowns of cdk9 and eto-2. Expression of embryonic �E1 was
normal, whereas reduced levels of runx1 were observed in the dorsal
aorta region at 0.5 pmol MO (n=8/13) and decreased further with
lmo4-MO injected at 1 pmol. In addition, some of the treated
embryos appeared to have brain or neural tube abnormalities, which
are the cause of perinatal death of the corresponding knockout
mouse (Hahm et al., 2004; Tse et al., 2004; Lee et al., 2005). These
mice showed no defects in the haematopoietic system, although only
half of the homozygous Lmo4 null mutants were born. The other half
died around E9 of gestation, possibly due to a haematopoietic
phenotype. The effects of the eto-2-, cdk9- and lmo4-MOs on the
definitive haematopoietic system were still observable after 2 days
(Fig. 5B) with normally circulating embryonic blood cells. At this
stage of development the reduction in body size of the embryos
injected with the eto-2-, cdk9-, lmo4- and mtgr1-MOs also became
more apparent (Fig. 5B).
We conclude that the newly identified Ldb1 interaction partners
eto-2, cdk9 and lmo4 are essential for definitive erythropoiesis in
zebrafish, whereas mtgr1 plays a less critical role. The fact that
embryonic haematopoieis is intact shows that the expression of tal1
and gata1 is not affected by knockdown of eto-2, cdk9 and lmo4. The
dorsal aorta is normally formed in such treated embryos, indicating
that the eto-2, cdk9 and lmo4 are not required for vasculogenesis. It
is noteworthy in this context that Eto-2 in zebrafish (this paper) and
most of its constitutive binding partners, namely HEB and E47 in
mouse (Zhuang et al., 1996) and Mtgr1 in mouse (Amann et al.,
2005) and zebrafish (this paper), are not required for embryonic
haematopoiesis.
Ldb1 interacting partners are expressed in the
same cells in the para-aortic splanchnopleura of
the early mouse embryo.
The results obtained for the novel Ldb1 interaction partners in the
zebrafish suggest that they would be expressed in the early mouse
embryo at stages prior to the ‘birth’ of the definitive haematopoietic
stem cells in the AGM (Durand and Dzierzak, 2005). We therefore
performed immunohistochemistry and immunofluorescence on E9.5
embryo sections (Fig. 6). Immunohistochemical analysis with �-
Ldb1, �-E2A, �-Lmo2, �-Gata1, �-Eto-2 and �-Cdk9 showed that
all are expressed in the para-aortic splanchnopleura (P-Sp), the
region destined to contribute to the AGM (Fig. 6A,B).
To further determine the expression pattern of the interacting
proteins and to confirm that cells within the P-Sp co-express these
proteins, we performed in situ immunofluorescence experiments on
the cryosections. We found that cells positive for Gata1 expression
also expressed Eto-2, Ldb1 and Runx1 (Fig. 6C). Cells expressing
Ldb1 were also positive for Runx1, E2A and Lmo2 (not shown).
Although we cannot analyse all of the proteins due to antibody
incompatibilities, the observation that Gata1 and Eto-2, Gata1 and
Ldb1, and Ldb1 and Runx1 are co-expressed in the pre-AGM cells
of the P-Sp suggests that they form a complex that may be essential
for the induction of the definitive haematopoietic system. The fact
that Eto-2 is predominantly cytoplasmic at that time (Fig. 6C,
column 3, panels Eto-2 and merge) suggests that it may respond to
extracellullar signals at the prehaematopoietic stage. At later stages
(fetal liver), it is abundant in the nucleus but its cytoplasmic
expression is very weak. (see Fig. S2 in the supplementary material).
DISCUSSION
Ldb1 forms dynamic complexes during erythroid
differentiation
By using a systems biology approach we identified all known and
many new binding partners of Ldb1 and determined their
importance for haematopoietic development. The important
implication of this work is that the analysis of proteins co-expressed
and interacting with each other in a late mature cell type are already
implicated at the earliest stages of, in this case, blood development.
The Ldb1 proteome has a number of interesting interactions: (1)
with Eto-2 (and Mtgr1); (2) with a large number of different bHLH
proteins; (3) with Cdk9; and (4) with the Ssdp proteins, although this
latter interaction was not analysed further. Recently we have shown
that Gata1 forms at least five clearly identifiable protein complexes
(Rodriguez et al., 2005). We did not observe such distinct complexes
for Ldb1. Clearly, Ldb1 forms a core complex with the known
partners Gata1, Tal1, Lmo2 and E2A, and the newly identified
partner Eto-2 (Fig. 6). Eto-2 also forms complexes with E2A and
Tal1 without Ldb1. In the sequential immunoprecipitations we can
distinguish between the preferential binding partners of Eto-2 and
Ldb1, and deduce the existence of a higher order complex the
formation of which is favoured in proliferating cells. At the same
time it is difficult to separate groups of interacting proteins from
each other by immunoprecipitations, especially if a protein interacts
with others in different combinations. Hence, we are in the process
of purifying the different complexes. With induction, levels of Eto-
2 decrease and formation of the large complex is lower (Fig. 7).
Cdk9, which has been linked to cell-cycle progression (Bettencourt-
Dias et al., 2004), would no longer be part of the complex. This may
explain why the cells stop proliferating upon differentiation. At the
same time, the levels of Lmo4 increase, possibly replacing
Lmo2/Eto-2 and leading to an activation of transcription of genes
expressed after terminal differentiation.












Noteworthy is the presence of a large number of DNA binding
proteins within the complex, particularly the presence of at least five
bHLH proteins and the zinc finger transcription factor Gata1. It is
possible that such a complex may very well be involved in the
establishment and/or facilitation of long-range interactions,
processes in which Ldb1 has been implicated (Morcillo et al., 1997).
Specifically, in Drosophila melanogaster, Chip was identified in a
screen for factors involved in the long-range gene activation of the
cut gene. Chip was proposed to bridge the Pannier (GATA) and
Achaete/Scute (bHLH) complexes causing the intervening DNA to
loop out bringing DNA control elements into close proximity
(Ramain et al., 2000). The erythroid Ldb1-Lmo2-Tal1-E2A-Gata1
complex may have a similar role. It was recently shown that the
complex binds to multiple sites in the �-globin locus (Anguita et al.,
2004). We envisage that these complexes also interact and promote
long-range interactions in other gene loci, for example in the �-
globin locus ACH (Tolhuis et al., 2002).
The Eto family members Eto-2 and Mtgr1 are thought to be
repressors by binding the NCor/Sin3A/HDAC1 (Gelmetti et al.,
1998; Lutterbach et al., 1998; Wang et al., 1998) complex. Eto-2
was the most abundant protein in the MS analysis, suggesting it
is a direct (and crucial) binding partner of Ldb1 (confirmed by
immunoprecipitations). We also observed that Eto-2 and its
family member Mtgr1 interact with each other. Moreover Eto-2
appears to be the bridging factor for Ldb1 to interact with Mtgr1
(Fig. 3, and see Fig. S1A in the supplementary material). Eto
proteins and the D. melanogaster orthologue nervy have four
highly conserved protein interaction domains (Davis et al., 1999;
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Fig. 6. Ldb1 interacting partners are expressed in the P-Sp. (A) Haematoxylin stained 10 �m transversal cryosection of a E9.5 FvB embryo. The
area of the P-Sp is indicated by the box. (B) High magnification (�1000) of the areas such as shown in (A). Expression of Cdk9, E2A, Ldb1, Lmo2
and Gata1 was detected with specific antibodies and visualised with DAB. IgG panel shows the background staining with an unspecific IgG
antibody. (C) Immunofluorescence analysis of E9.5 embryos with �-Eto-2, �-Ldb1, �-Runx1 and �-Gata1 antibodies. Specific staining is seen for
both Eto-2 (green) and Gata1 (red) antibodies (second column), compared with the IgG control (first column). (Third column) Enlargement of the
section shown in the second column. Merge is a superposition of images of the Eto-2 and Gata1 detection; cells that express both Eto-2 and Gata1
appear as yellow. The overlay of Gata1 and DAPI staining shows exclusive nuclear localisation of Gata1, whereas Eto-2 is seen in the nucleus and
cytoplasm. (Fourth column) Ldb1- (green) and Gata1- (red) expressing cells are located in the dorsal aorta region; most of the cells positive for Ldb1
are also positive for Gata1 (Ldb1 is also expressed in other cell types). A similar pattern is shown for Gata1- (red) and Runx1- (green) expressing cells














Davis et al., 2003). The DNA binding of the Eto-2 complexes we
describe probably occurs through its bHLH binding partners
and/or Gata1.
Interestingly, with induction Eto-2 and the Eto-2/Ldb1 complex
decrease, while the level of Lmo4 increases. Thus, the level of the
large Ldb1-Eto-2 complex drops to be replaced by one with
Lmo4. Complementary results were obtained by other groups
through characterisation of Tal1 complexes (Schuh et al., 2005;
Goardon et al., 2006). As indicated by the chromatin
immunoprecipitation experiments, the repressive role of
Eto-2 may very well explain how late erythroid genes become
activated. An alternative or complementary explanation may
be post-translational protein modifications of the Eto-2
complex members, a possibility that cannot be excluded at
present.
A good candidate to carry out modifications and change
specific interactions is Cdk9. This CDC2 orthologue precipitated
differentially with Ldb1 in proliferating and differentiating
C88 cells. The invariance of the main isoform independent of
the cell-cycle stage has been reported (Garriga et al., 2003). Cdk9
is thought to have two functions: regulating RNA polymerase II
by phosphorylating its C-terminal domain (Marshall et al., 1996;
Zhu et al., 1997); and regulating the cell cycle. A ‘knockdown’ of
the D. melanogaster orthologue of Cdk9 causes an arrest at the
G1 to S transition (Bettencourt-Dias et al., 2004), congruent
with the in vitro data that the human CDK9 orthologue
phosphorylates Rb (Graña et al., 1994). Interestingly, Gata1 has
been found to interact with Rb in vitro (Whyatt et al., 1997).
We detect an interaction between Cdk9 and Ldb1 only in
noninduced, proliferating C88 cells, suggesting Ldb1 and its
partners might be involved in transcriptional control of the cell
cycle through the dual function of Cdk9. Putative target genes
could be E2F family members expressed in haematopoietic cells.
Cdk9 also interacts with BRG1 and STAT3 to activate
transcription of the cell-cycle inhibitor p21waf1 (Giraud et al.,
2004), suggesting that Cdk9 has different functions in the cell
cycle depending on its partners. In this context it is interesting that
we detect Eto-2 protein in the cytoplasm of haematopoietic stem
cell precursors (Fig. 6) and of developing neurons (N.M.,
unpublished). Eto-2 may respond to extracellular signals by
translocating from the cytoplasm into the nucleus, while it is
downregulated in terminally differentiating cells. This suggests
that Eto-2 plays a key role in the development of the definitive
HSCs, and is required for the subsequent phases of expansion of
the different lineages. It then needs to be downregulated to allow
the activation of late genes such as Eklf for terminal
differentiation.
Late erythroid differentiation complexes and
early haematopoiesis
It is remarkable that the analysis of interacting proteomes of Gata1
(Rodriguez et al., 2005) and Ldb1 (this paper) in late erythroid cells
has resulted in the identification of a number of proteins essential for
early haematopoiesis (as found in the zebrafish experiments), in
particular Lmo4, Cdk9 and Eto-2.
Lmo4 expression in mice has been detected at E9 from the caudal
region of the dorsal and lateral paraxial mesoderm up to the direct
vicinity of the dorsal aorta, suggesting that Lmo4 could play a role
in HSC formation (Kenny et al., 1999). Lmo4 is also upregulated in
late T cell differentiation (Kenny et al., 1999) similar to that
observed in C88 cells. In Xenopus, Xlmo4 and Gata-2 act
synergistically in ventral mesoderm formation. However, an
Xlmo4-MO did not prevent ventral mesoderm formation (de la
Calle-Mustienes et al., 2003). In zebrafish, lmo4 is expressed at
gastrulation but not during ventral mesoderm formation (Lane et
al., 2002). In accordance with this, we found embryonic
haematopoiesis in lmo4-MO-treated zebrafish embryos to be
normal. We show the expression of lmo4 at later stages to be
important for the formation of definitive HSCs in zebrafish.
Whether the same phenotype is observed in mice remains to be
determined.
MO-mediated repression of eto-2 had the most drastic phenotype
in zebrafish – absence of runx1 expression in embryonic
erythrocytes and lack of definitive haematopoiesis, suggesting it is
essential for runx1 expression at that stage. Cdk9-MO-treated
embryos lacked definitive cells. However in embryonic blood cells
runx1 expression was detected, suggesting Cdk9 does not regulate
runx1 directly.
The fact that these factors are already co-expressed in the same
cells in the murine P-Sp before the generation of the definitive HSCs
in the AGM (de Bruijn et al., 2000) suggests that they are also
essential for definitive haematopoiesis in the mouse. Eto-2 and Cdk9
may be more important in this process than Gata1, because loss of
Gata1 is not deleterious to these very early stages (with cytoplasmic
Eto-2). This in turn suggests that Tal1, Ldb1 and Lmo2 are dominant
at this stage. Because all of the Ldb1-bound Gata1 is complexed
with Eto-2, we postulate that when Eto-2 translocates from the
cytoplasm to the nucleus, the balance of interactions is changed
causing the transition to a more proliferative Gata1-driven phase
followed by terminal differentiation.
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Fig. 7. Model of Ldb1 complexes in uninduced MEL cells. The horizontal arrows indicate that the balance of interaction is towards the large
complex in proliferating noninduced cells. Upon the induction of differentiation and termination of proliferation the level of Eto-2 drops whereas
the level of Lmo4 rises, hence the equilibrium would shift towards the smaller complexes. The presence of several DNA binding proteins in a single
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in	 humans.	 It	 is	 a	 rare	 dominantly	 inherited	 multisystem	 disorder	 affecting	 both	
physical	 and	mental	 development.	 Heterozygous	mutations	 in	 the	Delangin	 gene	
were	 found	 in	 about	 half	 of	 CdLS	 cases.	 To	 understand	 the	 role	 of	 Delangin	 in	
mammals,	 we	 generated	mice	 lacking	Delangin.	Homozygous	mutants	 are	 lethal	
early	in	development.	Heterozygous	mice	are	born	exhibiting	the	characteristics	of	









Cell	 proliferation	 depends	 on	 genome	 duplication	 and	 segregation	 of	 sister	
chromatids	to	opposite	poles	of	the	cell	prior	to	division.	Cohesin	is	a	protein	complex	
that	keeps	sister	chromatids	 together	 from	 the	 time	of	 replication	 in	S	phase	until	
their	separation	at	the	onset	of	anaphase,	a	process	that	is	essential	for	the	correct	
segregation	of	chromosomes	during	mitosis.	The	Cohesin	proteins	are	evolutionarily	
conserved	 across	 species	 (Hirano,	 2006;	Nasmyth	 and	Haering,	 2005).	 The	 core	
complex	consists	of	SMC1	and	SMC3,	members	of	the	SMC	(Structural	Maintenance	






of	 Cohesin	 with	 chromatin	 requires	 the	 SMC	 proteins	 to	 have	 a	 functional	 hinge	









regulation	arose	 from	studies	on	gene	silencing	 in	yeast	and	on	 long-range	gene	
activation	 in	Drosophila	 (Donze	 et	 al.,	 1999;	 Rollins	 et	 al.,	 1999).	 In	more	 recent	
studies	it	was	shown	that	Cohesin	has	a	role	in	neuronal	development	in	Drosophila 
(Pauli	et	al.,	2008;	Schuldiner	et	al.,	2008).	Loss	of	Cohesin	binding	in	dividing	cells	
resulted	 in	 Precocious	 Sister-Chromatid	 Separation	 (PSCS)	 while	 in	 non-dividing	
cells	it	resulted	in	defects	in	axonal	pruning	(Pauli	et	al.,	2008).	In	vertebrates,	early	
studies	that	 identified	Cohesin	as	a	factor	 in	 the	regulation	of	 the	particular	genes	
focused	on	the	expression	of	runx	genes	in	zebrafish.	The	combination	of	a	genetic	
screen	and	morpholino	experiments	 revealed	 that	Rad21	and	SMC3	are	essential	







is	 embryonic	 lethal,	 with	 apparent	 developmental	 defects,	 indicating	 that	 	 Pds5	















































with	Cohesin	subunits	 in	 regulating	sister	chromatid	cohesion	does	not	extend	 to	









retardation,	 microcephaly,	 severe	 mental	 retardation	 with	 speech	 delay,	 feeding	




retardation	 are	 less	 severe	 (Ireland	 et	 al.,	 1993;	 Jackson	 et	 al.,	 1993).	 Affected	
individuals	 are	 typically	 identified	 as	 sporadic	 cases	 though	 several	 reports	 have	
documented	families	with	multiple	affected	members	(Russell	et	al.,	2001).





Generation of Delangin-deficient mice
The	role	of	Delangin	was	examined	in	mice	carrying	a	targeted	allele	shown	in	




conserved	among	 the	species	a	disruption	at	exon	10	 is	highly	unlikely	 to	yield	a	
functional	protein.	Homologous	integration	of	the	construct	in	the	genome	results	in	
the	production	of	GFP-protein	from	the	endogenous	promoter.	Three	heterozygous	














Heterozygous	mice	exhibit	difficulties	 in	breeding	making	 it	 very	difficult	 to	obtain	
homozygous	 null	 mice.	 However	 no	 viable	 homozygous	 embryos	 were	 detected	
during	 embryonic	 development	 at	 different	 time	 points	 starting	 from	 6.5	 E	 days	
(25	embryos	were	analyzed)	concluding	 that	 the	homozygous	deletion	 is	an	early	
embryonic	lethal	event.		To	generate	heterozygous	mice	for	analysis	we	used	crosses	




Delangin deficiency results in size reduction of the embryos and 
aberrant postnatal growth
The	 WT	 (Wild	 type)	 embryos	 were	 indistinguishable	 from	 mutant	 once	 until	
embryonic	day	16.	From	day	E16.5	the	mutants	began	to	show	signs	of	progressive	
growth	retardation.	Newborn	Delangin-deficient	mice	are	drastically	smaller	from	WT	


























(Top)	The	genomic	region	before	 targeting	around	exon	10	 is	shown	with	 the	position	of	a	unique	
EcoRV	site	where	the	neo-cassette	is	inserted	and	the	positions	of	HindIII	and	SacI	restriction	sites	
used	to	identify	legitimate	recombination	events.
(Middle)	The	 targeting	construct	 (in	 the	5’	 to	3’	direction)	consisting	of	neomycin	 resistance	gene	
flanked	by	 lox	P	 sites	 linked	 (black	 ellipses)	 to	 a	GFP	 reporter	 gene	and	NEO-polyA	under	PMC	
(mutated	polyoma	enhancer).
(Bottom)	 The	 genomic	 arrangement	 after	 targeting	with	 the	 positions	 of	 the	 restriction	 fragments	














heterozygous	 mice	 are	 smaller	
from	 WT	 littermates	 with	 up	 to	
50%	reduction	in	body	weight.
(B)	 The	weight	 difference	of	 one	
litter	 followed	 during	 11	 weeks	
showing	 a	 substantial	 difference	
but	similar	ratio	of	weight	gain.	
(C)	 The	 weight	 distribution	 of	
Delangin-deficient	 mice	 and	 WT	
(2	months	old).	Note	a	significant	
difference	 between	 two	 groups	
for	either	males	or	females.	
74 Chapter	3
High lethality and a complex, heterogeneous and not fully penetrant 
















Since	 Delangin-deficient	 mice	 suffer	 from	 respiratory	 distress	 and	 perinatal	
lethality,	we	examined	cardiac	malformation	in	affected	animals.	In	many	cases,	we	
could	detect	severely	dilated	cardiomyopathy	that	is	not	seen	in	the	control	animals	
(Figure	 3	 A	 and	 B).	 The	 diameter	 of	 the	 myocytes	 is	 less	 than	 normal	 in	 many	
instances.	Fibrosis	is	also	detected	in	the	heart	muscle	(Figure	3	C	and	D).	These	
abnormalities	 can	cause	 the	 respiratory	distress	and	contribute	 to	early	postnatal	
lethality.		Patients	with	CdLS	often	have	congenital	heart	defects.
Young	 Delangin-deficient	 mice	 developed	 respiratory	 insufficiency	 whereas	















































Heart	 and	 lung	 abnormalities	 in	
Delangin-	deficient	mice
(A-D)	Heart	abnormalities
(A-B)	 Severe	 cardiomyopathy	 in	
Delangin-deficient	mice	(B)	that	is	not	
seen	in	WT	(Wild	Type)	animals	(A).
(C-D)	 Fibrosis	 and	 hyperatrophic	










mice	 are	 atrophic	 with	 disrupted	
alveolar	walls	(F	and	K)	compared	to	
WT	(E	and	G).
WT	 wild	 type;	 M	 mutant,	 Delangin-	
deficient
B	 bronchus;	 AP	 arteria	 pulmonaris;	






that	 result	 in	poorly	defined	cortical	 and	medular	 structures.	 The	 thymic	cortex	of	
Delangin-deficient	mice	is	atrophic	and	depleted	of	T	lymphocytes	resulting	in	a	loss	
of	corticomedullary	distinction.
Delangin-deficient	mice	do	not	display	 limb	or	digit	 truncations,	or	 loss	of	any	
other	bone	elements	features	that	can	be	observed	 in	a	subset	of	 individuals	with	


























The	 overall	 mucosa	 height	
is	 drastically	 decreased	 in	
Delangin-deficient	 mice	 (B	 and	
D)	 compared	 to	 WT	 (A	 and	
C).	 Note	 the	 difference	 in	 the	
thickness	of	muscularis	mucosa	
(MM)	 and	 muscularis	 externa	
(ME).







The	 thymic	 architecture	 is	
disturbed	 with	 poorly	 defined	
cortical	and	medullar	structures	






The	 yeast	 homologues	 of	 Delangin (Scc2)	 is	 important	 for	 sister	 chromatid	



















Delangin heterozygous eS cells are sensitive to γ-radiation and 
slightly sensitive to uV light
The	Delangin	homologues	SCC2	in	yeast,	and	Pqn-85	in	C. elegans,	have	been	




Cell	 survival	 of	 the	 Delangin-deficient	 ES	 cells	 after	 exposure	 to	 damaging	































































Generation of Delangin heterozygous mice






and	 transfected	 by	 electroporation	 into	 to	 IB10	 cells.	 Homologous	 recombinants	
were	screened	by	Southern	blot	hybridization	using	genomic	DNA	that	was	digested	
with	SacI	 restriction	 enzyme	 giving	 two	 different	 fragments:	 10.1	 kb	 for	WT	 allele	
and	7.3kb	 for	 targeted	allele.	The	probe	 is	situated	at	 the	3’	end	of	 the	construct.	
Three	 targeted	ES	clones	with	 the	correct	 karyotype	were	 injected	 into	blastocyst	




























deficient	 littermates.	 Blood	 was	 first	 lysed	 in	 Gey’s	 lysis	 solution	 for	 	 removal	 of	




















The	sensitivity	 of	ES	cells	 to	 increasing	doses	of	DNA-damaging	agents	was	









solution	 for	 48hours	 at	 4oC.	 The	 necropsy	 is	 completed	 the	 organs	 weight	 were	
measured.	 The	organs	were	embedded	 in	paraffin	 and	were	 serially	 sectioned	at	
6μm	thickness,	stained	with	Hematoxylin	and	Eosin	and	examined	microscopically.
DISCuSSIOn
In	 eukaryotic	 cells,	 replicated	 DNA	 molecules	 remain	 physically	 connected	
from	 the	moment	 of	 synthesis	 in	 S-phase	 until	 their	 separation	during	 anaphase.	










through	 chromosomal	 dynamics	 or	 through	 alternative	 functions	 in	DNA	damage	
repair	or	 transcriptional	regulation.	 It	 is	very	well	possible	that	a	combination	of	all	
these	processes	is	involved	in	the	observed	phenotypes.	
In	this	work,	we	have	generated	Delangin-deficient	mice	that	manifest	a	spectrum	
of	 developmental	 abnormalities,	 similar	 to	 those	 seen	 in	CdLS	patients.	 In	CdLS,	
mutations	 in	 the	Delangin	 gene,	 even	 in	 a	 presence	 of	 a	 wild-copy	 of	 the	 gene,	
triggers	a	haploinsuffiency	in	the	Cohesin	pathway.	Mutations	in	the	Cohesin	pathway	















Delangin-deficient	mouse	model	 and	 the	CdLS	patients.	 The	 complex	 and	broad	
spectrum	of	 symptoms	observed	 in	 the	mice	 has	 an	 incomplete	 penetrance	 and	
variable	 expression	 which	 is	 in	 agreement	 with	 features	 seen	 in	 human	 patients.	
In	 the	CdLS	 patients	 symptoms	 vary	 from	mild	with	 no	 obvious	 defects,	 through	
moderate	ones	where	growth	and	mental	health	is	affected,	to	very	prominent	cases	
with	a	combination	of	limb	truncation,	severe	mental	and	growth	retardation.	






is	 improving,	 the	 molecular	 mechanism	 through	 which	 Delangin	 acts	 is	 still	 not	
clear.	In	mammalian	cells,	the	function	of	most	Cohesin	factors,	including	Cohesin	
and	Delangin	were	 investigated	by	RNA	interference.	However,	 the	most	desirable	
alternative	 system	 to	 study	 gene	 function	 and	 pathogenesis	 of	 the	 syndromes	 in	
mammalian	organism	is	undoubtedly	KO	mouse.	To	date,	the	only	mouse	models	
that	were	 generated	 are	 null	mutants	 of	 the	meiosos	 specific	 subunits	 Rec8	 and	
SMC1B,	which	are	both	sterile	(Revenkova	et	al.,	2004;	Xu	et	al.,	2005).	With	respect	







both	 isoforms	 of	 the	 Delangin	 (A	 and	 B)	 are	 inactivated	 so	 the	 possibility	 of	 the	
redundancy	with	the	alternative	isoform	is	excluded.	One	of	the			possibilities	is	that	
Premature	Sister	Chromatid	Separation	 	 (PSCS)	occurs	 in	particular	 cells	 that	we	
have	 not	 analyzed	 even	 though	we	 included	 several	 types	 of	 the	 cells:	 ES	 cells,	
Mouse	Embryonic	 Fibroblasts	 (MEFs)	 from	 embryonic	 tissues	 and	B-	 and	 T-cells	
from	adult	tissues.	The	lack	of	PSCS	in	our	mouse	model	favors	a	hypothesis	that	
defects	present	 in	CdLS	patients	are	 related	 to	Cohesin-mediated	 functions	other	
than	sister	chromatid	cohesion.	We	also	did	not	detect	aneuploidy,	often	seen	as	a	
consequence	of	premature	chromatid	segregation.	Aneuploidy	often	leads	to	tumor	
formation	 in	organisms	with	 this	 type	of	 chromosome	 instability.	 The	 incidence	of	
a	tumor	formation	in	the	Delangin-deficient	mice	was	very	low,	(to	date	only	in	one	
animal).	 This	 is	 	 in	 agreement	 with	 the	 infrequent	 occurrence	 of	 tumors	 in	 CdLS	




homologous	 recombination	during	 the	S-and	G2	phase	of	 the	cell	 cycle	 (Sjogren	
and	Nasmyth,	2001).	Inactivation	of	SCC2	(Delangin)	or	one	of	the	Cohesin	subunits	
results	in	a	reduced	efficiency	of	post-replicative	DSB	repair	in	G2	/M.	In	the	studies	
presented	by	Strom	et	al.	 	 (Strom	et	al.,	2004)	 	and	Unal	et	al.	 (Unal	et	al.,	2004)	
was	demonstrated	 that	 the	 local	enrichment	of	Cohesin	depends	on	 the	Delangin	









Delangin	 are	 reflected	 on	 Cohesion	 targets.	 Misregulation	 of	 a	 single	 gene	 can	
have	 severe	 downstream	 effect	 especially	 during	 development.	 The	 expression	
of	 a	 number	 of	 genes	 crucial	 for	 development,	 such	 as	 homeotic	 genes,	 could	




of	hematopoietic	and	other	 lineages	 (Horsfield	et	al.,	 2007).	 If	we	 think	about	 the	
possibility	 that	 Delangin	 mutation	 causes	 inappropriate	 loading	 or	 positioning	 of	
Cohesin	on	its	target,	in	this	case	runx	gene,	the	consequence	is	deregulation	of	runx	
gene	expression	and	runx	downstream	targets.
	 In	 another	 scenario,	 chromatin	 organization	 can	also	be	affected.	Studies	 in	
human	 and	 mouse	 cells	 have	 shown	 that	 Cohesin	 accumulates	 at	 sites	 bound	
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interactions	 between	 cis-regulatory	 elements	 on	 the	 same	 loop	 and	 diminishing	
the	 influence	of	more	distant	elements	on	other	 loops	 thereby	maintaining	proper	
expression	 domains	 and	 patterns	 in	 a	 lineage	 specific	 manner.	 This	 task	 is	






Insulators	are	best	exemplified	by	 the	gypsy	element	 in	Drosophila	 (Capelson	
and	Corces,	2005).	The	Gypsy	insulators	are	occupied	in	a	sequence	specific	manner	
by	SUHW	and	Mod	 (Mdg4)	which	 recruit	 other	 factors	 (Pai	 et	 al.,	 2004).	Multiple	
gypsy	sites	and	associated	proteins	cluster	together	to	form	“insulator	bodies”	with	
the	effect	of	organizing	nearby	chromatin	into	loop	domains	(Capelson	and	Corces,	
2006).	 In	 vertebrates,	 a	 similar	 function	 is	 associated	 with	 the	 chromatin	 binding	
protein	CTCF	(CCCTC-binding	factor).	It	is	the	prototype	vertebrate	protein	exhibiting	
insulator	activity	 	as	an	enhancer	blocker	or	as	a	barrier	against	 inactivation	 from	










The	 mouse	 β-globin	 locus	 is	 situated	 on	 chromosome	 7	 and	 contains	 four	
functional	genes:	εγ, βh1, βmaj		and	 βmin	(from	5’to	3’).	During	primitive	eryhropoiesis,	
yolk	sac	derived	erythroid	cells	express	mostly	εy and βh1,	while	the	expression	of	
βmaj and βmin	 is	 low.	 In	 the	murine	β-globin	 locus,	 three	CTCF-binding	 sites	 have	












is	 best	 known	 for	 its	 role	 in	 holding	 sister	 chromatids	 together	 after	 eukaryotic	
DNA	replication.	This	allows	 the	spindle	 to	 recognize	pairs	of	 replication	products	
for	segregation	 into	opposite	directions	during	mitosis.	The	complex	 is	conserved	

































the	shared	CTCF/Cohesin	binding	sites.	We	show	 that	Cohesin	binding	 is	 indeed	
required	in	a	CTCF	dependent	manner.	
ReSuLtS
Identification of Cohesin and CtCF binding sites by ChIP-on chip
Cohesin	and	CTCF	binding	sites	were	identified	by	Chromatin	Immunoprecipitation	
(ChIP)	in	mouse	I/11	cells.	I/11	cells	are	erythroid	progenitor	cells	established	from	
fetal	 livers	of	p53-/-	mice.	The	cells	can	be	expanded	 indefinitely	 in vitro	and	after	
exposure	 to	 physiologically	 relevant	 stimuli	 such	 as	 erythropoietin,	 they	 undergo	
terminal	differentiation	into	enucleated	erythrocytes	in	a	synchronized	manner	(von	
Lindern	et	al.,	2001).	The	choice	of	I/11	cells	was	based	on	their	ability	to	faithfully	
recapitulate	 the	 erythroid	 differentiation	 program	 in vivo.	 Analysis	 of	 this	 erythroid	







































		 The	 identification	 of	Cohesin	 and	CTCF	binding	 sites	by	ChIP-sequencing	
was	 done	 as	 described	 above	 for	 the	 ChIP-on-chip	 analysis.	 The	 quality	 of	 the	
chromatin	precipitation	was	confirmed	by	using	real-time	quantitative	PCR	analysis	
of	known	target	sites	before	further	analysis	using	the	Solexa	1G	Genome	Analyzer.	
The	 sequencing	 procedure	 requires	 a	 one-step	 adaptor	 ligation	 and	 limited	 PCR	
amplification	(18	cycles)	of	ChIP	DNA	molecules	followed	by	cluster	generation	and	
sequencing-by-synthesis	 (Described	 in	Materials	 and	Methods).	 One	 sequencing	





overlapping	 sites	 situated	at	 the	chromosome	1	and	9	with	 relevant	 controls	 and	
the	positions	along	 the	chromosomes	 (Mouse	Build	37.1).	 The	statistical	 analysis	











































































































Cohesin binding to 3’HS1 in the β-globin locus is dependent on 
CtCF











on	 the	presence	of	CTCF,	suggesting	 that	CTCF	 is	 required	 for	 the	enrichment	of	
Cohesin	at	its	binding	sites.	However	we	were	unable	to	detect	a	direct	interaction	
between	 CTCF	 and	 any	 of	 the	 Cohesin	 subunits	 (data	 not	 shown).	 Possibly	 the	
interaction	is	weak	or	Cohesin	and	CTCF	interact	only	transiently.	Alternatively	they	
may	interact	indirectly	via	other	proteins	or	DNA.	
























of	 its	DNA	binding	site	destabilize	 specific	 long-range	 interactions	 (Splinter	et	 al.,	
2006)	we	asked	the	question	what	the	contribution	of	Cohesin	is	to	range	interactions	
in	the	β-globin	locus	using	a	3C	interaction	analysis	(Splinter,	Heath	et	al.	2006).	We	
were	unfortunately	not	able	 to	 include	 the	2	newly	 identified	CTCF/	Cohesin	 sites	
(B1	and	B2)	in	this	analysis	since	they	are	surrounded	by	repetitive	DNA	sequences	
that	 prevent	 a	 proper	 primer	 design.	 We	 analyzed	 the	 known	 contacts	 within	 β-
globin	DNA	in	erythroid	cells	 lacking	CTCF	(not	shown,	Splinter,	Heath	et	al	2006)	
or	SMC3	(Cohesin)	protein.	 In	case	of	the	SMC3	Knock	Down	CTCF	is	still	bound	












































































































the	prototype	vertebrate	 insulator	protein,	had	already	been	strongly	 implicated	 in	
mediating	gene	regulation,	chromatin	structure	and	organization	of	gene	loci	before	











adjacent	to	the	genes	(Wendt	et	al.,	2008),	 favoring	the	possibility	 that	 these	sites	
have	a	role	 in	gene	regulation.	Since	Cohesin	accumulates	at	CTCF-binding	sites,	
it	 is	 tempting	 to	 speculate	 that	 Cohesin	 stabilizes	 the	CTCF-mediated	 interaction	




functional	relevance	of	 the	shared	sites	 is.	 It	 is	also	not	clear	what	keeps	Cohesin	














and	CTCF	 shared	binding	 sites	 is	 the	 lack	 of	 knowledge	 about	 the	 interaction	 of	
Cohesin	with	DNA.	 The	 commonly	most	 accepted	 “ring”	model,	 proposes	 that	 a	
tripartite	 ring	 formed	 by	 SMC1,	 SMC3	 and	 SCC1/Rad21	 encircles	 two	 10-nm	
chromatin	fibers	but	is	not	contacting	the	DNA	directly	(Haering	et	al.,	2002).	Perhaps	






depletion	appears	 to	 influence	 the	 interaction	between	CTCF	binding	sites	 in	 two	
opposing	 ways.	 First	 Cohesin	 depletion	 prevents	 the	 HS-85	 site	 from	 contacting	





of	 Cohesin	 results	 in	 the	 selective	 loss	 of	 “weaker”	 interactions,	 i.e.	 the	 HS-85.	
Although	the	experiment	should	be	extended	into	a	more	detailed	analysis	that	also	
takes	the	novel	B1	and	B2	sites	into	account,	it	is	tempting	to	speculate	about	other	
possibilities.	For	example	other	 factors	might	stabilize	 loops	 formed	by	CTCF	and	
these	 	 compete	with	Cohesin	mediated	 interactions.	 This	would	 also	 explain	why	
















Primary	 fetal	 liver	 cells	were	 isolated	 from	p53-/-	mice	as	described	 (Splinter,	
Heath	 et	 al	 2006).	 We	 maintained	 proliferating	 I/11	 cells	 in	 (StemPro-34	 SFM,	
Invitrogen)	 containing	 0.5	 units/ml	 of	 erythropoietin,	 100	 ng/ml	 stem	 cell	 factor	
and	1mM	dexamethasone.	Proliferating	cells	were	expanded	and	kept	at	a	density	
between	1.5x106	and	3x106	cells/ml.	To	induce	differentiation,	proliferating	cells	were	
























Probe Labeling and Microarray Hybridization
ChIP	 DNA	 was	 amplified	 and	 labeled	 according	 to	 the	 standard	 Affymetrix	







to	 mouse	 chromosomes	 according	 to	 NCBIv33	 (mm5)	 genome	 assembly.	 The	
samples	 (CTCF-non	 induced,	CTCF-induced,	SMC3-non	 induced,	SMC3-induced,	
IgG-non	induced,	IgG-induced	and	2	genomic	input	samples	from	non	induced	and	
induced	I/11	cells)	were	normalized	in	groups.	The	genomic	DNA	corresponding	to	
every	ChIP-enriched	 region	 identified	by	 tiling	 array	was	 retrieved	 from	 the	UCSC	
genome	browser	with	a	suitable	version	or	IGB	(Integrated	Genome	Browser)	from	
Affymetrix.	













Kit	 in	 15	ul	EB	 (Qiagen).	One	microliter	of	 each	sample	 library	was	quantified	on	
Bioanalyzer	(Agilent	Technologies)	using	a	DNA1000	assay.	A	10	nM	DNA	stock	in	
EB	was	prepared	for	each	sample.	





Sequencing	 user	 guide	 protocol	 (www.illumina.com).	 Sequencing	 reagents	 were	
prepared	 as	 described	 in	 the	Genome	Analyzer	 reagents	 protocol	 (www.illumina.
com).	After	hybridization	of	the	seq-primer	sequencing	by	synthesis	was	performed	
using	 the	Genome	Analyzer	 and	a	36-cycle	protocol	 according	 to	manufacturer’s	
instructions.	Images	are	analyzed	by	the	Illumina	GAP	pipeline.	
The	 raw	 data	 from	 the	 Illumina	 Genome	 Analyzer	 was	 processed	 using	 a	
combination	 of	 the	 IPAR	 (Integrated	 Primary	 Analysis	 Reporting	 Software)	 using	
version	1.0	of	the	GAP	(Genome	Analyzer	Pipeline),	Inc.			The	resultant	sequences	
were	 mapped	 against	 NCBI	 build	 37.1	 of	 the	 mouse	 genome	 using	 the	 ELAND	
alignment	software	(Anthony	J.	Cox,	Illumina	Inc.,	unpublished	work).
	




T4	DNA	 ligase	at	 16	 0C	 for	 4hr.	After	 reversing	 the	crosslinks,	genomic	DNA	was	
purified	by	phenol	extraction	and	ethanol	precipitation.	For	PCR	analysis,	the	linear	
range	of	amplification	was	for	the	samples	by	serial	dilution.	An	appropriate	of	DNA	
within	 the	 linear	 range	was	subsequently	used	 for	 the	experiments.	PCR	products	
were	run	on	2%	agarose	gels	and	quantified	on	a	Typhoon	imager.	All	data	points	
were	generated	from	an	average	of	3	different	experiments	performed	in	duplo.		




(GenBank	 accession	 no.	 NM_007794.1,	 NM_181322.2)	 was	
	5’CCGGGCAGAGAAAGTAGTTGGTAATCTCGAGATTACCAACTACTTTCTCTGCTTTTTG	3’











on	 I/11	 cells	 by	Western	 blot.	 GFP	 control	 construct	 was	 used	 for	 measuring	 of	
transduction	efficiency.	Transduced	cells	were	selected	with	puromycin	and	harvested	
every	day	for	WB	analysis,	and	4	and	5	day	for	additional	Chip	analysis	and	3C.
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Critical Role for the Transcription Regulator CCCTC-Binding
Factor in the Control of Th2 Cytokine Expression1
Claudia Ribeiro de Almeida,2*† Helen Heath,2‡ Sanja Krpic,‡ Gemma M. Dingjan,*
Jan Piet van Hamburg,* Ingrid Bergen,† Suzanne van de Nobelen,‡ Frank Sleutels,‡
Frank Grosveld,‡ Niels Galjart,3‡ and Rudi W. Hendriks3†
Differentiation of naive CD4� cells into Th2 cells is accompanied by chromatin remodeling at the Th2 cytokine locus allowing the
expression of the IL-4, IL-5, and IL-13 genes. In this report, we investigated the role in Th2 differentiation of the transcription
regulator CCCTC-binding factor (CTCF). Chromatin immunoprecipitation analysis revealed multiple CTCF binding sites in the
Th2 cytokine locus. Conditional deletion of the Ctcf gene in double-positive thymocytes allowed development of peripheral T cells,
but their activation and proliferation upon anti-CD3/anti-CD28 stimulation in vitro was severely impaired. Nevertheless, when
TCR signaling was circumvented with phorbol ester and ionomycin, we observed proliferation of CTCF-deficient T cells, enabling
the analysis of Th2 differentiation in vitro. We found that in CTCF-deficient Th2 polarization cultures, transcription of IL-4, IL-5,
and IL-13 was strongly reduced. By contrast, CTCF deficiency had a moderate effect on IFN-� production in Th1 cultures and
IL-17 production in Th17 cultures was unaffected. Consistent with a Th2 cytokine defect, CTCF-deficient mice had very low levels
of IgG1 and IgE in their serum, but IgG2c was close to normal. In CTCF-deficient Th2 cultures, cells were polarized toward the
Th2 lineage, as substantiated by induction of the key transcriptional regulators GATA3 and special AT-rich binding protein 1
(SATB1) and down-regulation of T-bet. Also, STAT4 expression was low, indicating that in the absence of CTCF, GATA3 still
operated as a negative regulator of STAT4. Taken together, these findings show that CTCF is essential for GATA3- and SATB1-
dependent regulation of Th2 cytokine gene expression. The Journal of Immunology, 2009, 182: 999–1010.
P rotection against pathogens relies on the ability of T cellsto give rise to various effector cell fates upon activation.Classically, naive CD4� T cells are thought to undergo
programmed differentiation into mainly two functionally distinct
subsets, termed Th1 and Th2 (for review, see: Refs. 1 and 2). Th1
cells, which produce IFN-�, are predominantly involved in cellular
immunity against intracellular pathogens. Two major signaling
pathways facilitate Th1 development, one involving IL-12/STAT4
and the other involving IFN-�/STAT1/T-bet (3–5). Th2 cells, pro-
ducing IL-4, IL-5, and IL-13, mediate humoral immunity and are
essential for the eradication of parasitic worms, but also mediate
allergic responses. Th2 cytokine production is dependent on the
transcription factor GATA3, which is rapidly induced by IL-4
through STAT6 (6–10). Recently, a distinct effector T cell subset
has been described, termed Th17. These cells produce IL-17 and
control a wide range of infections at mucosal surfaces and are
implicated in the pathogenesis of several autoimmune diseases first
thought to be caused by deregulated Th1 function (reviewed in
Ref. 2). In mice, both TGF-� and IL-6 are required to drive Th17
differentiation through activation of the orphan nuclear receptors
ROR�t and ROR� (11, 12). Differentiation of pathogenic Th17
cells is developmentally related to anti-inflammatory Foxp3� reg-
ulatory T (Treg)4 cells, which can be generated in vitro by stim-
ulation with TGF-� in the absence of IL-6 (13).
Subset-specific expression of cytokine genes in T cells involves
unique transcriptional, epigenetic, and structural mechanisms.
When naive T cells are stimulated with Ag, they show low tran-
scription of both IFN-� and Th2 cytokines (14, 15). Th2 cytokine
gene promoters and the Th2 locus control region come into close
spatial proximity to form a higher-order chromatin structure, sug-
gesting that early expression of the Th2 cytokines in naive T cells
is supported by an initial “poised” chromatin configuration (16).
Upon Th2 differentiation, a substantial increase in the transcrip-
tional activity of IL-4, IL-5, and IL-13 and concomitant silencing
of IFN-� are observed. The converse pattern of gene activation and
silencing is present in differentiating Th1 cells. Such polarized
patterns of cytokine gene expression are achieved through the ac-
tivation of cell type-specific transcription factors and chromatin
remodeling proteins which bind to cis-regulatory elements of cy-
tokine genes, thus initiating substantial and reciprocal alterations
in the chromatin structure of the IFN-� and Th2 cytokine loci
(reviewed in Refs. 17 and 18). Indeed, both STAT6 and GATA3
are responsible for the establishment and/or maintenance of the
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chromatin conformation changes in the Th2 cytokine locus of de-
veloping Th2 cells (16, 19). Particularly, because GATA3 can in-
duce chromatin-remodeling activity (20), it may facilitate the in-
teraction between the Th2 locus control region and the cytokine
gene promoters and thereby coregulate IL-4, IL-5. and IL-13 ex-
pression. In addition, Th2 cytokine expression requires special
AT-rich binding protein 1 (SATB1), which mediates the formation
of a densely looped, transcriptionally active chromatin structure at
the Th2 locus containing GATA3, STAT6, c-Maf, the chromatin-
remodeling enzyme Brg1, and RNA polymerase II (21).
The 11-zinc finger protein CCCTC-binding factor (CTCF) is a
ubiquitously expressed and highly conserved transcriptional regu-
lator implicated in many key processes within the nucleus, includ-
ing promoter activation and repression, hormone-responsive gene
silencing, and genomic imprinting (for review, see Ref. 22). CTCF
often binds in the vicinity of insulators, elements that affect gene
expression by preventing the spread of heterochromatin (acting as
“barrier”) and inhibiting inappropriate interactions between regu-
latory elements on adjacent chromatin domains (acting as “en-
hancer blocker”) (23). It has been shown that CTCF is required for
the enhancer-blocking activity of insulators (24). Consistent with a
role for CTCF as an insulator protein, we have shown that in the
mouse �-globin locus, CTCF mediates long-range chromatin loop-
ing and regulates local histone modifications (25). However,
CTCF binding is not always required for chromatin insulation (26,
27). Combined, these data establish CTCF as an important protein
involved in long-range DNA interactions and the regulation of
active and repressive chromatin marks.
Genome-wide mapping of CTCF binding sites (CBS) in the hu-
man genome identified �14,000 sites, whose distribution corre-
lated with genes but not with transcriptional start sites (28, 29).
Domains with few or no CTCF sites tend to include clusters of
transcriptionally coregulated genes, whereby these regions are of-
ten flanked by CTCF binding sites (28, 30). The genome-wide
analyses also revealed CTCF binding sites near genes displaying
extensive alternative promoter usage, including protocadherin �,
the Ig � L chain, and the TCR �/�- and �-chain loci. In mice,
CTCF binding was observed downstream of the TCR �/� and the
Ig H chain loci (31, 32). Very recently, CTCF was found to control
MHC class II gene expression and long-range chromatin interac-
tions between MHC class II promoter regions (33). These data
imply an important role for CTCF in lymphocytes, in particular in
the regulation of gene transcription in complex loci. We have re-
cently found that conditional inactivation of Ctcf early in thymo-
cyte development resulted in a severe arrest of early T cell devel-
opment (34). Our findings indicated that CTCF regulates cell cycle
progression of �� T cells in the thymus (34).
In this report, we investigated whether CTCF is important for
Th2 cytokine expression. Chromatin immunoprecipitation (ChIP)
assays revealed the presence of multiple CTCF binding sites in the
Th2 cytokine locus. We show that conditional deletion of the Ctcf
gene in the thymus, using CD4-Cre mice, allowed the generation
of peripheral T cells, albeit with reduced numbers. In vitro polar-
ization cultures of CTCF-deficient CD4� T cells revealed a Th2
cytokine expression defect, despite normal induction of the tran-
scription factors GATA3 and SATB1.
Materials and Methods
Mice
T cell-specific deletion of Ctcf was achieved by breeding Ctcff/f mice (34),
which were crossed on the C57BL/6 background for �10 generations to
CD4-Cre mice (35), which were provided by Dr. C. Wilson (University of
Washington, Seattle, WA). OT-II-transgenic mice have been described pre-
viously (36). Mice were genotyped by Southern blotting or by PCR using
Cre-specific primers. Mice were bred and maintained in the Erasmus MC
animal care facility under specific pathogen-free conditions and analyzed at
6–10 wk of age. Experimental procedures were reviewed and approved by
the Erasmus University committee of animal experiments.
RNA and protein analyses
Total RNA was extracted using the GeneElute mammalian total RNA
miniprep system (Sigma-Aldrich). Primers spanning at least one intron-
exon junction were designed either manually or using the ProbeFinder
software (Roche Applied Science). Probes were chosen from the universal
probe library (Roche Applied Science) or designed manually (GATA3,
Gapdh) and purchased from Eurogentec. Quantitative real-time PCR was
performed using an Applied Biosystems Prism 7700 sequence detection
system. To confirm the specificity of the amplified products, samples were
separated by standard agarose gel electrophoresis. Threshold levels were
set and further analysis was performed using the SDS version 1.9 software
(Applied Biosystems). Obtained cycle threshold values were normalized to
cycle threshold values of Gapdh or �-actin. Each PCR was performed at
least in triplicate. Primer sequences and PCR conditions used are available
on request.
Nuclear extracts were prepared and analyzed by Western blot (37). Abs
specific for CTCF (N3) and fibrillarin have been previously described (34).
Alternatively, anti-CTCF antiserum was purchased from Millipore. Anti-
DNMT1 was from Abcam and anti-UBF, anti-SATB1, and anti-fibrillarin
were from Santa Cruz Biotechnology. Primary Ab incubation was done
overnight at 4°C in TBS containing 5% (w/v) BSA and 0.15% (v/v) Non-
idet P-40. Blots were incubated with secondary goat anti-rabbit or mouse
Abs coupled to HRP (GE Healthcare). Signal detection was performed
using ECL (Amersham Biosciences). Western blots were scanned and
quantified using the gel macro function in ImageJ (W. S. Rasband, National
Institutes of Health, Bethesda, MD; http://rsb.info.nih.gov/ij/).
ChIP assay
ChIP followed by ultrahigh-throughput DNA sequencing on I11 erythroid
cells was performed using a Solexa 1G Genome Analyser (38). ChIP anal-
ysis of CTCF binding in the Th2 cytokine locus was performed as de-
scribed in the ChIP Assay Kit protocol (Upstate Biotechnology) using the
anti-CTCF Abs listed above or IgG as control. Quantitative real-time PCR
(Bio-Rad IQ5) on immunoprecipitated DNA was performed using SYBR
Green (Sigma-Aldrich) and Platinum Taq DNA Polymerase (Invitrogen).
Enrichment was calculated relative to Necdin and values were normalized
to input measurements. The sequences of the primers used were as follows:
CBS-1F, 5�-GGTCTTAGCAGGTTCCCAA-3�; CBS-1R, 5�-CGTTCGG
TAAGACAAGCAC-3�; CBS-2F, 5�-CACTCAGCACCTTACCTG-3�;
CBS-2R, 5�-CCTGGGCTAAATGAATCAGT-3�; CBS-3F, 5�-AGGCA
CAGTGTAGAAGTGT-3�; CBS-3R, 5�-GTCTCTCTTCCAGTCCAGTT-
3�; CBS-4F, 5�-GGCACTTGTAACGCTCTAA-3�; CBS-4R, 5�-CCCTG
ACCAACATCTCCAA-3�; CBS-5F, 5�-ATTGTGGAGGCTGGCAAG-
3�; CBS-5R, 5�-GGTGACAGCCCAAATAAGT-3�; CBS-6F, 5�-CCA
CATCCACCTGTCACTT-3�; CBS-6R, 5�-CTGTTTCACATCCATC
GCA-3�; CBS-7F, 5�-CAGGCTTGTATCATCACCA-3�; and CBS-7R,
5�-TTCTTGAGGGACAGCACT-3�.
Flow cytometric analyses
Preparation of single-cell suspensions and mAb incubations for four-color
cytometry has been previously described (39). All mAbs were purchased
from BD Biosciences except for PE-conjugated anti-granzyme B (GB12;
Caltag Laboratories), anti-GATA3 (Hg-3-31; Santa Cruz Biotechnology),
allophycocyanin-conjugated anti-Foxp3 (FJK-16s; eBioscience), biotinyl-
ated anti-IL-13 (R&D Systems), and allophycocyanin-conjugated IL-10
(JES5-16E3; eBioscience).
For intracellular detection of cytokines, cells were restimulated with
plate-bound anti-CD3 (10 �g/ml in PBS; 145-2C11) or PMA (50 ng/ml;
Sigma-Aldrich) plus ionomycin (500 ng/ml; Sigma-Aldrich) in the pres-
ence of GolgiStop (BD Pharmingen) for 4 h. Cells were harvested and
stained extracellularly, followed by standard intracellular staining using
paraformaldehyde and saponin. Foxp3 expression was evaluated by intra-
cellular staining using a Foxp3 buffer set (eBioscience).
Cell cycle status of T cell cultures was determined after fixing in ice-
cold ethanol and subsequent staining in PBS containing 0.02 mg/ml pro-
pidium iodide, 0.1% v/v Triton X-100, and 0.2 mg/ml RNase. Doublet cells
were excluded by measuring peak area and width. CFSE labeling of cells
was performed as described elsewhere (40).
Samples were acquired on a FACSCalibur or FACS LSRII flow cytom-
eter and analyzed using CellQuest (BD Biosciences) or FlowJo (Tree Star)
research software.
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In vitro T cell cultures
For in vitro T cell stimulations and Th1/Th2 polarization cultures, naive
CD62L�CD4� or CD8� T cells were purified by cell sorting using a
FACSVantage VE equipped with Diva Option and BD FACSDiva soft-
ware (BD Biosciences). The purity of obtained fractions was �98%.
For ChIP experiments, CD4� T cells from C57BL/6 mice were obtained
through incubation with biotinylated mAbs (BD Pharmingen) specific for
CD11b (M1/70), Gr-1 (RB6-8C5), Ter119 (Ly-76), TCR�� (GL3), B220
(RA3-6B2), NK1.1 (PK136), and CD8 (53-6.7), followed by streptavidin-
conjugated microbeads and autoMACS purification according to the man-
ufacturer’s instruction (Miltenyi Biotec). The purity of CD4� T cell frac-
tions was confirmed by FACS to be �95%.
T cell fractions were cultured at a concentration of 1 � 106 cells/ml in
IMDM (BioWhittaker) containing 10% heat-inactivated FCS, 5 � 10�5 M
2-ME, 100 U/ml penicillin, and 100 �g/ml streptomycin. Stimulation was
with plate-bound anti-CD3 (145-2C11) and anti-CD28 (37.51) mAbs
(coated at 10 �g/ml each at 4oC overnight) or PMA (50 ng/ml) plus iono-
mycin (300 ng/ml). For Th1-polarizing conditions, anti-IL-4 (10 �g/ml;
11B11) and IL-12 (10 ng/ml) were added to the medium. Th2-polarizing
cultures included anti-IFN-� (5 �g/ml; R4-6A2,), anti-IL-12 (5 �g/ml;
C17.8), and IL-4 (10 ng/ml). Treg- and Th17-polarizing conditions in-
cluded TGF-� (3 ng/ml), anti-IL-4, and anti IFN-�. Th17-polarizing con-
ditions additionally contained IL-6 (20 ng/ml). For Th0 conditions, no
cytokines or mAbs were added. For differentiation of CD8� effector T
cells, only rIL-2 (5 ng/ml) was added to the medium. For Th0, Th1, and
Th2 cultures, cells were supplemented with IL-2 (5 ng/ml) on day 3 after
activation and expanded up to day 7 under the same cytokine conditions as
the primary cultures. In Th17 cultures, cells were restimulated with PMA
plus ionomycin at day 3, supplemented with TGF-� and IL-6 and expanded
up to day 5. All cytokines were from R&D Systems.
Stimulation of OT-II-transgenic CD4� T cells was conducted in the
presence of bone marrow-derived dendritic cells (BM-DC). Briefly, BM
single-cell suspensions were prepared from C57BL/6 femurs and seeded at
2 � 106 per petri dish in complete IMDM and 200 ng/ml murine GM-CSF
(BioSource International). On days 3 and 6, 200 ng/ml murine GM-CSF
was added in 10 ml of fresh IMDM. On day 8, the nonadherent cells
consisting of immature and mature BM-DC were harvested. For in vitro T
cell proliferation studies, 0.2 � 106 CFSE-labeled OT-II-transgenic naive
CD4� T cells were cocultured with 0.2 � 106 BM-DC previously pulsed
with OVA peptide323–339 (50 �g/ml) in complete IMDM. At day 4, cul-
tured T cells were harvested for proliferation analysis.
ELISA
In vitro-polarized Th2 cells were harvested after 7 days in culture and
washed twice with culture medium. Cells were resuspended (1.5 � 106
cells/ml) in fresh culture medium containing PMA (50 ng/ml) plus iono-
mycin (300 ng/ml). Three days later, supernatants were harvested and an-
alyzed for the presence of cytokines using eBioscience (IL-4 and IL-5) and
R&D (IL-13) ELISA systems.
Total serum Ig levels were determined by subclass-specific sandwich
ELISA, as described; IgE was induced by i.p. injection of 10 �g of 2,4,6-
trinitrophenyl-keyhole limpet hemocyanin (TNP-KLH) precipitated on
alum (41).
Statistical evaluations
All statistical evaluations were done with Student’s t test.
Results
CTCF binding sites in the Th2 cytokine locus
CTCF binding sites in the human Th2 locus have recently been
identified in CD4� T cells (30). Taking into account that CTCF
binding sites are largely invariant between cell types (28), we first
used ChIP coupled to ultrahigh-throughput DNA sequencing data
obtained in mouse I11 erythroid cells (S. Krpic and F. Grosveld,
manuscript in preparation) to gain insight into CTCF binding in the
murine Th2 cytokine locus. We identified four CTCF binding sites
(CBS-1, CBS-3, CBS-6, and CBS-7) encompassing the 200-kb
region containing the Il5, Rad50, Il13, Il4, and Kif3a genes (Fig.
1A). These sites, as well as three other CTCF binding sites (CBS-2,
CBS-4, and CBS-5), have been reported to be occupied in mouse
embryonic stem cells (42). We subsequently analyzed CTCF-bind-
ing to CBS-1 to CBS-7 in cultured Th1 and Th2 cells by ChIP. For
these experiments, MACS-purified CD4� T cells from spleen and
lymph nodes were stimulated with anti-CD3/CD28 under Th1-po-
larizing conditions (with IL-12 and anti-IL-4 Abs) or Th2-polar-
izing conditions (with IL-4, anti-IL-12, and anti-IFN-� Abs) for 7
days. Quantitative real-time PCR analyses showed that CTCF
binding to CBS-1, CBS-3, CBS-6, and CBS-7 was significantly
increased when compared with IgG control, both in Th1- and Th2-
polarized cells (Fig. 1B). A similar enrichment at these sites was
also found in PMA/ionomycin- activated Th1- and Th2-polarized
cells (data not shown). Thus, the Il-4, Il-5, and Il-13 genes in the
Th2 locus are flanked by CBS-6 and CBS-7 upstream of the Il-5
gene and CBS-1 downstream of the Il-4 gene, within the Kif3a
gene. Interestingly, CBS-3 is located in the intergenic region be-
tween the Il-13 and Il-4 genes, close to a conserved noncoding
sequence, designated CNS-1, which has been shown to be critical
FIGURE 1. CTCF binding sites in the
murine Th2 cytokine locus. A, Schematic
representation of the Th2 cytokine locus and
CTCF binding sites (CBS-1 to CBS-7). CBS
were identified by a bioinformatics approach
in combination with ChIP assays. B, ChIP
analysis in Th1 and Th2 cells. Analysis was
performed with CTCF (f) or IgG (�) Abs
in 7-day polarized Th1 or Th2 cells. Mean
values and SD are given for two ChIP ex-
periments; �, p � 0.05 and ��, p � 0.01.
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for GATA3 binding and Th2 cytokine expression (43, 44). Our
data indicate that the CTCF protein binds to CBS-1, CBS-3,
CBS-6, and CBS-7, irrespectively, of Th1 or Th2 polarization.
Conditional deletion of the Ctcf gene in T lymphocytes
To study CTCF function in vivo, we generated a conditional Ctcf
allele (Ctcff) by inserting a loxP site upstream of exon 3 and a loxP
site along with a lacZ reporter downstream of exon 12 (Fig. 2A)
(34). We bred Ctcff/f mice to mice carrying a Cre-encoding trans-
gene under the control of the CD4 promoter (35). Southern blotting
showed almost complete deletion of the Ctcf gene in the thymus of
CD4-Cre Ctcff/f mice, whereas in the spleen Ctcf deletion was only
partial, reflecting the presence of many non-T lineage cells (Fig.
2B). To evaluate the onset of Ctcff gene deletion, we analyzed
thymocyte subpopulations for expression of the Ctcf-lacZ fusion
transcript, using fluorescein-di-�-D-galactopyranoside as a substrate
FIGURE 2. Conditional targeting of the mouse Ctcf gene. A, Simplified map of the WT murine Ctcf locus and modified alleles. Top line, WT Ctcf allele,
with exons shown as solid boxes, and position of HindIII sites (H) and the Southern blot probe (arrow) indicated. Middle line, Floxed Ctcf allele (Ctcff).
Two targeting cassettes were inserted into the Ctcf gene via consecutive rounds of homologous recombination. The first cassette contained LoxP sites (Œ)
flanking a PMC1-driven neomycin resistance gene (neor), the second cassette contained LoxP sites flanking a PGK-driven puromycin resistance gene
(puror), followed by a splice acceptor-lacZ cassette (SA-LacZ). Bottom line, deleted Ctcf gene (Ctcf�) generated after complete Cre-mediated recombination
at the outermost loxP sites. For details on constructs and targeting, see Heath et al. (34). The small horizontal lines underneath each allele represent HindIII
fragments recognized by the probe in the Southern blot analysis of B below. B, Southern blot analysis of CD4-Cre recombinase activity. HindIII-digested
genomic DNA from thymus and spleen of mice of the indicated genotypes was analyzed by hybridization with a CTCF locus-specific probe (see
A). The positions of the WT, Ctcff/f (flox), and Ctcf�/� (del) alleles are indicated (asterisk indicates a polymorphic WT allele from the FVB
background). C, Western blot analysis of sorted naive CD62L�CD4� and CD8� T cell fractions from nontransgenic (�) or CD4-Cre-transgenic (�)
Ctcff/f mice were analyzed for CTCF. DNMT1 and UBF were used as loading controls. D, Flow cytometric analysis of lacZ expression in CTCF
conditionally deleted mice. LacZ expression was analyzed in conjunction with cell surface markers. The indicated cell populations were gated and
lacZ expression data are displayed as histogram overlays of CD4-Cre Ctcff/f mice (green) on top of the background signals in WT mice (black). ISP,
Immature SP.
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in conjunction with cell surface markers. Consistent with the re-
ported CD4-Cre activity at the double-negative (DN) stage (45),
Ctcf deletion was initiated in DN cells (DN2 to DN4) and com-
pleted from the immature single-positive (ISP) cell stage onward
(Fig. 2D). Despite efficient deletion of the Ctcf gene in the thymus,
residual CTCF protein was still detectable in purified fractions of
peripheral naive CD62L�CD4� and CD8� T cells (�25% of con-
trol; Fig. 2C), indicating that CTCF is a remarkably stable protein
in resting naive T cells.
To examine the effects of Ctcf deletion on T cell development,
thymocyte subpopulations from 6- to 8-wk-old CD4-Cre Ctcff/f
mice and wild-type (WT) littermates were analyzed by flow cy-
tometry. CD4-Cre Ctcff/f mice displayed low thymic cellularity,
with reduced numbers of double-positive (DP), CD4, and CD8
single-positive (SP) cells, when compared with WT controls (Fig.
3, A and B). The CD4�CD8� thymocyte fraction had a relative
increase of CD3lowCD69low ISP cells and a decrease of
CD3�CD8� SP cells. Consistent with impaired thymic SP cell
production, the numbers of mature CD4� and CD8� T cells in
spleen and lymph nodes of CD4-Cre Ctcff/f mice were signifi-
cantly reduced (Fig. 3, A and C, and data not shown). Further-
more, the numbers of �� T cells in the spleens of CD4-Cre
Ctcff/f mice were increased (Fig. 3C).
In summary, in CD4-Cre Ctcff/f mice, �� T cell development is
partially arrested at the DP stage, resulting in a significant reduc-
tion of the numbers of peripheral CD4� and CD8� T cells.
Defective TCR/CD3-mediated proliferation of CTCF-deficient
CD4� and CD8� T cells
To investigate cellular activation of CTCF-deficient T cells, we
performed in vitro stimulation experiments with highly purified
naive CD62L�CD4� and CD8� peripheral T cells. We evaluated
their ability to go through sequential cell divisions by CFSE la-
beling and observed severely reduced proliferation of anti-CD3/
CD28-activated CTCF-deficient CD4� T cells at day 3 (Fig. 4A).
Proliferation was not only defective when standard conditions of
10 �g/ml anti-CD3/anti-CD28 were used, but also when we in-
creased either of the two (or both) Ab concentrations to 50 �g/ml
(data not shown). Next, the capacity of CTCF-deficient CD4� T
cells to proliferate upon a more physiological, Ag-specific stimu-
lation was investigated by crossing CD4-Cre-Ctcff/f mice with OT-
II-transgenic mice, which harbor a TCR specific for OVA peptide.
Upon activation by OVA peptide323–339-pulsed APC, survival of
nondividing (WT and CTCF-deficient OT-II-transgenic CD4� T
cells was similar, but we noticed a severe proliferation defect in the
absence of CTCF (Fig. 4A). Although anti-CD3/CD28-activated
FIGURE 3. Defective TCR�� lineage development in CTCF-deficient mice. A, Flow cytometric analyses of the indicated cell populations in thymus
or spleen fromWT and CD4-Cre Ctcff/f mice. Expression profiles of surface markers are shown as dot plots and the percentages of cells within the quadrants
or gates are given. B and C, Absolute numbers of the indicated thymic and splenic T cell subpopulations. Each symbol represents one individual animal
and lines indicate average values. Values of p of significant differences between WT and CD4-Cre Ctcff/f mice are indicated.
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CTCF-deficient CD8� T cells were able to undergo cell division,
they lagged behind WT cells by approximately one cell cycle, and
cell recovery was reduced when compared with WT CD8� T cells
(Fig. 4A).
PMA bypasses proximal TCR signaling events and directly acti-
vates protein kinase C signaling (46). Under conditions where PMA
was added as a costimulatory signal with anti-CD3, CTCF-deficient
cells showed defective proliferation. However, when T cells were
stimulated by PMA and the calcium ionophore ionomycin (which
raises the intracellular level of Ca2�), we observed significant prolif-
eration of CTCF-deficient CD4� and CD8� T cells (Fig. 4A).
Consistent with limited cell division observed in the CFSE ex-
periments, anti-CD3/CD28-stimulated CTCF-deficient CD4� T
cell cultures showed diminished cell recovery and an almost com-
plete lack of cells in the S-G2-M phase of the cell cycle (Fig. 4B).
Although CTCF-deficient PMA/ionomycin-stimulated CD4� or
CD8� T cell cultures exhibited lower expansion rates, their cell
cycle profiles at day 3 were similar to those from WT cells (Fig.
4B). In vitro proliferation of CD4-Cre Ctcff/f T cells did not reflect
a specific expansion of rare cells that have escaped CTCF deletion,
as CTCF protein levels were severely reduced both in CD8� (Fig.
4C) and in CD4� T cell cultures (see Fig. 9C).
Taken together, these findings demonstrate that conditional de-
letion of the Ctcf gene in DP thymocytes allows development of
peripheral T cells, but their activation and proliferation upon anti-
CD3/anti-CD28 stimulation in vitro is severely impaired. Never-
theless, when TCR signaling is circumvented with phorbol ester
and ionomycin, CTCF-deficient T cells have the capacity to pro-
liferate, indicating that in this context loss of CTCF can be com-
pensated for by signaling molecules or nuclear factors induced by
PMA/ionomycin. These results therefore indicate that CTCF is not
absolutely required for cell proliferation.
Defective TCR/CD3-mediated activation of CTCF-deficient
CD4� and CD8� T cells
Next, we investigated whether defective proliferation of CTCF-
deficient T cells was caused by impaired cellular activation.
Binding of IL-2 to its receptor is a critical event in the initiation
of T cell proliferation, since it regulates transition of the cell
cycle from G1 into S phase (47). Therefore, we investigated
FIGURE 4. Impaired anti-CD3�-medi-
ated proliferation of CTCF-deficient T
cells. A, CFSE profiles of T cell cultures
of sorted CD62L�CD4� and CD8� T
cell populations fromWT mice (gray his-
tograms) in comparison to cultures from
CD4-Cre Ctcff/f mice (black line). Cells
were activated by the indicated stimuli
and cultured for 3 days (or 4 days for
OT-II CD4 T cells). Dotted lines indicate
the fluorescence intensity of unstimu-
lated cells. B, Cellular expansion in
3-day cultures upon anti-CD3/CD28 or
PMA/ionomycin stimulation (upper
part). Symbols represent the expansion
values of cultures from individual mice,
whereby cell numbers at the start of the
culture were set to one; lines indicate av-
erage values. Values of p of significant
differences between WT and CD4-Cre
Ctcff/f mice are indicated; n.s., not signif-
icant. The lower part shows the cell cycle
status of the indicated cultures, whereby
DNA content was examined by pro-
pidium iodide (PI) staining. The percent-
ages of cycling cells (S-G2-M phase) are
shown. C, Western blotting analysis of
naive CD62L�CD8� T cells from WT or
CD4-Cre-transgenic Ctcff/f mice cultured
for 5 days and examined for CTCF lev-
els. Fibrillarin was used as a loading
control.
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whether CTCF-deficient T cells had an IL-2 production defect or
impaired IL-2R induction. We found that upon stimulation with
anti-CD3/CD28 or PMA/ionomycin, the absence of CTCF did not
affect IL-2 production in CD4� or CD8� T cells, as analyzed by
intracellular cytokine staining at day 3 (Fig. 5A). By contrast, in-
duction of the IL-2 receptor CD25 on CTCF-deficient CD4� and
CD8� T cells was severely impaired, when activated by plate-bound
anti-CD3/CD28 (Fig. 5B). When activated by PMA/ionomycin,
CTCF-deficient CD4� T cells displayed a partial defect in CD25 up-
regulation, while in CD8� T cells CD25 induction was normal.
Expression of CD69, an �30-kDa glycoprotein induced in ac-
tivated T cells, was hampered in CTCF-deficient CD4� T cells
upon TCR stimulation, but was normal in CD8� T cells or in
PMA/ionomycin-stimulated CTCF-deficient T cells. Finally, anal-
yses of forward scatter values of stimulated cells showed that cell
size increases in CTCF-deficient cells were limited, particularly
upon anti-CD3/CD28 stimulation, whereby CD4� cells were more
affected than CD8� cells (Fig. 5B).
From these findings, we conclude that anti-CD3/CD28 treatment
does not elicit proper activation of CTCF-deficient peripheral T
cells, in terms of induction of CD25, CD69, and cell size increase,
whereby CD4� T cells are somewhat more affected than CD8� T
cells. However, when T cells are stimulated by PMA/ionomycin,
expression levels of CD25 and CD69 are largely in the normal
ranges.
CD4-Cre Ctcff/f mice have severely reduced serum levels of
IgG1 and IgE
Concentrations of Ig subclasses in the serum of CD4-Cre Ctcff/f
mice were reduced, except for IgM and IgG3, which are T cell
FIGURE 6. Serum Ig analysis in CTCF-deficient mice. A, Serum con-
centrations of Ig isotypes displayed as average values plus SD. Mice were
2 mo of age. B, Total IgE serum concentrations in nonimmunized mice
(left) and in immunized mice 7 days after i.p. injection with 10 �g TNP-
KLH (right).
FIGURE 5. Impaired cellular activation of CTCF-de-
ficient T cells. A, Analysis of IL-2 expression in anti-
CD3/CD28 and PMA/ionomycin-stimulated cultures
of sorted CD62L�CD4� and CD8� T cell fractions
from WT and CD4-Cre Ctcff/f mice. At day 3, cells were
restimulated for 4 h before intracellular flow cytometric
analysis. Total living cells were gated and CD4/IL-2 and
CD8/IL-2 profiles are displayed as dot plots and the per-
centages of cells within the quadrants are given. Data
shown are representative of four mice per group. B, Phe-
notypic characteristics of anti-CD3/CD28 or PMA/iono-
mycin-stimulated CD4� and CD8� T cells. CD25,
CD69, and forward scatter profiles are displayed as his-
togram overlays of WT (gray histograms) and CD4-Cre
Ctcff/f cultures (bold lines). The percentages shown rep-
resent the fractions of the cells within the indicated
marker in WT (gray) or CD4-Cre Ctcff/f (black, bold)
cultures. Data shown are representative of four to six
mice per group.
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independent and IgA which requires TGF-� expression (Fig. 6A).
This does not necessarily mean that CTCF-deficient CD4� T cells
produce normal levels of TGF-�, since this cytokine is secreted by
many cell types.
Interestingly, serum levels of the IL-4-dependent isotype IgG1
were more affected than those of the IFN�-dependent isotype
IgG2c (�10 and �60% of WT, respectively). Serum concentra-
tions of the IL-4-dependent isotype IgE were also lower in the
absence of CTCF (Fig. 6B). Moreover, when Th2-mediated re-
sponses were tested in vivo by injection of a low dose of TNP-
KLH in alum (10 �g), we observed an increase in the concentra-
tion of total IgE in WT mice at day 10, but not in CD4-Cre Ctcff/f
animals (Fig. 6B). Thus, the absence of CTCF resulted in a severe
deficiency for the Th2-dependent subclasses IgG1 and IgE in the
serum, whereas the Th1-dependent subclass IgG2c was only mod-
erately affected. CD4-Cre Ctcff/f mice also had very low levels of
IgG2b in the serum. Because class switch recombination to IgG2b
is thought to be regulated by various cytokines including IFN-�
and TGF-�, but not by Th2 cytokines, the IgG2b deficiency cannot
be explained by a selective Th2 defect.
Th2 cytokine defect in CD4-Cre Ctcff/f mice
Next, we performed in vitro polarization cultures to investigate
whether CTCF is specifically required for differentiation of Th2
effector cells. Sorted naive CD62L�CD4� T cells from spleen
and lymph nodes were stimulated with anti-CD3/CD28 or
PMA/ionomycin under Th0 conditions (without additional cy-
tokines or Abs), Th1-polarizing conditions (with IL-12 and anti-
IL-4), or Th2-polarizing conditions (with IL-4, anti-IL-12, and
anti-IFN-�) for 7 days. Under these conditions, anti-
CD3/CD28-stimulated WT CD4� T cell fractions manifested a
�10- to 100-fold expansion in 7 days (Fig. 7A). Consistent with
the observed severely defective proliferation of anti-
CD3/CD28-stimulated CTCF-deficient CD4� T cells, we found
that the expansion of these cells at day 7 was negligible. Importantly,
replacing anti-CD3/CD28 by PMA/ionomycin stimulation resulted in
significant expansion of CTCF-deficient T cell cultures (�2–10 times
at day 7; Fig. 7A), enabling the analysis of Th1 and Th2 development
in vitro. Under these conditions, WT Th cultures showed an �10- to
30-fold expansion (Fig. 7A).
FIGURE 7. CTCF regulates Th2 cytokine expression. A, Expansion of Th0, Th1, and Th2 cultures 7 days after stimulation with anti-CD3/CD28 or
PMA/ionomycin. Symbols represent the expansion values of cultures from individual mice, whereby cell numbers at the start of the culture were
set to 1. Lines indicate average values. Values of p of significant differences between WT and CD4-Cre Ctcff/f mice are indicated. B, Flow cytometric
analysis for intracellular expression of IFN-� and IL-4 in the indicated T cell cultures after stimulation with PMA/ionomycin. CD4� T cells were
gated and expression profiles are displayed as dot plots. The percentages of cells within the quadrants are given. Mean fluorescence values for IL-4
were 138 and 75 for WT and CD4-Cre Ctcff/f IL-4� Th2 cells, respectively. C, Flow cytometric analysis for intracellular expression of the indicated
cytokines after stimulation with PMA/ionomycin. Total cells and CD4� T cells were gated and expression profiles are displayed as CD4/IL-5 and
IL-10/IL-13 dot plots, respectively. D, Cytokine levels of WT (�) and CD4-Cre Ctcff/f (f) Th2 cultures supernatant after stimulation with
PMA/ionomycin. Mean values and SD are given for two seven mice analyzed per group; �, p � 0.05 and ��, p � 0.01. E, Quantitative RT-PCR
analysis of expression of the indicated cytokines in different T cell cultures (WT, �; CD4-Cre Ctcff/f, f). Expression levels were normalized for
GAPDH and are expressed as arbitrary units, whereby the values in WT Th2 cells were set to 1. Mean values and SD are given for four mice analyzed
per group; �, p � 0.05 and ��, p � 0.01.
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In Th1-polarized cultures, CTCF-deficient T cells produced
moderately reduced levels of IFN-� when compared with WT T
cells, as determined by intracellular flow cytometry (Fig. 7B). The
proportions of IFN-�� cells were 55 � 15% (n � 7) and 23 � 6%
(n � 4; p � 0.005) in WT and CTCF-deficient Th1 cultures, re-
spectively. Remarkably, CTCF-deficient T cells showed a more
severe IL-4 production defect in Th2-polarized cultures. Both the
frequency of IL-4� T cells (51 � 11% (n � 7) in WT and 9 � 4%
(n� 4; p� 0.00005) in CTCF-deficient cultures) and intracellular
IL-4 signals per cell were significantly reduced in the absence of
CTCF (Fig. 7B). Additional intracellular flow cytometry analyses
showed that in CTCF-deficient Th2 cell cultures IL-5 production
was not detectable and IL-10 and IL-13 were severely reduced
(Fig. 7C). Consistent with these findings, in the supernatants of
Th2-polarized cultures, production of IL-4, IL-5, and IL-13 was
significantly reduced in the absence of CTCF, as determined by
ELISA (Fig. 7D). Finally, quantitative RT-PCR analysis of day 7
cultures showed that in CTCF-deficient Th2 cultures transcription
of the IL-4, IL-5, and IL-13 cytokines was strongly reduced (Fig.
7E). We also analyzed transcription of the Il-10 gene, which is not
located within the Th2 locus, and found that in the absence of
CTCF IL-10 expression was very low, both in Th1 and Th2
cultures.
Thus, in CTCF-deficient Th2 polarization cultures in vitro, tran-
scription of IL-4, IL-5, and IL-13 was strongly reduced. By con-
trast, CTCF deficiency had a moderate effect on IFN-� production
in Th1 cultures.
Th17 and Treg differentiation in CD4-Cre Ctcff/f mice
The observed Th2 cytokine defect in CTCF-deficient Th2 cells
prompted us to investigate whether differentiation toward alternative
CD4 T cell fates, including Th17 and Treg cells, was possible in the
absence of CTCF. We activated sorted naive CD62L�CD4� T cells
with PMA/ionomycin and cultured them under Th17 conditions (in
the presence of TGF-�, IL-6, anti-IFN-�, and anti-IL-4) or Treg con-
ditions (with TGF-�, anti-IFN-�, and anti-IL-4). As examined in
CSFE experiments, we observed significant proliferation of CTCF-
deficient CD4� T cells under Th17 and Treg conditions at day 3 (Fig.
8A). When Th17 cultures were analyzed for intracellular cytokines at
day 5, we found that the expression of IL-17 in CTCF-deficient T
cells reached values that were similar to those found in WT T cells
(�8%, n� 6; Fig. 8B). In addition, we noticed a small but consistent
population of IFN-�� cells in CTCF-deficient Th17 cultures, which
was not detected in WT Th17 cultures.
When naive WT CD62L�CD4� T cells were cultured under
Treg conditions for 3 days, a large majority of cells (85 � 2%,
FIGURE 8. CTCF is not essential for
Th17 or Treg differentiation. A, CFSE
profiles of Th0, Th17, and Treg cultures
of sorted CD62L�CD4� T cell popula-
tions from WT mice (gray histogram) in
comparison to cultures from CD4-Cre
Ctcff/f mice (black line). Cells were acti-
vated with PMA/ionomycin and cultured
for 3 days. Dotted lines indicate the flu-
orescence intensity of unstimulated cells.
B, Flow cytometric analysis for intracel-
lular expression of IFN-� and IL-17 in
Th0 and Th17 cultures after stimulation
with PMA/ionomycin. CD4� T cells
were gated and expression profiles are
displayed as dot plots. The percentages
of cells within the quadrants are given. C,
Flow cytometric analysis for intracellular
Foxp3 and IL-17 expression in PMA/
ionomycin-stimulated Treg cultures.
CD4� T cells were gated and expression
profiles are displayed as dot plots. D,
Flow cytometric analysis for intracellular
Foxp3 and membrane CD25 with quan-
tification of CD25�Foxp3� Treg cells in
spleen and mesenteric lymph nodes in
vivo. Data shown are representative of
four to six mice per group.
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n � 3; Fig. 8C) expressed Foxp3, the transcription factor associ-
ated with Treg differentiation (48). Such Foxp3� cells were also
present in Treg cultures of CTCF-deficient T cells, albeit that the
proportions were slightly lower (62 � 2%; n � 3). Furthermore,
the proportions of naturally occurring CD25�Foxp3�CD4� Treg
cells in spleen and lymph nodes in vivo were not different between
WT and CTCF-deficient mice (Fig. 8D).
As a control, we also evaluated IFN-� and granzyme B expres-
sion in day 7 cultures of anti-CD3/CD28- or PMA/ionomycin-
stimulated CD62L�CD8� T cells. We found that production of
IFN-� and granzyme B was only moderately affected (data not
shown).
Collectively, these findings show that differentiation of CTCF-
deficient T cells into IL-17-producing Th17 cells is apparently nor-
mal and lack of CTCF has limited effects on differentiation of Treg
and CD8� T cells. We therefore conclude that the absence of
CTCF does not result in a global defect in effector T cell
differentiation.
GATA3 and SATB1 expression in CD4-Cre Ctcff/f Th2 cells
Because Th2 cytokine production depends on the transcription fac-
tor GATA3 (6–10), we evaluated its expression in the T cell cul-
tures. As determined by intracellular flow cytometry, GATA3 ex-
pression appeared unaffected in CTCF-deficient Th2 cultures (Fig.
9A), excluding the possibility that Th2 cytokine production was
impaired due to defective GATA3 induction. Furthermore, the
CTCF-deficient Th2 cultures displayed clear features of Th2- po-
larized cells, including low mRNA levels of T-bet and STAT4
(Fig. 9B). Since GATA3 has the capacity to inhibit STAT4 tran-
scription (49), the finding of low STAT4 expression levels suggest
that in the absence of CTCF GATA3 still operated as a negative
regulator of STAT4. In CTCF-deficient Th1 cultures, T-bet ex-
pression was reduced when compared with WT (Fig. 9B), which is
consistent with the observed reduction in IFN-� expression. Next
to GATA3, SATB1 has also been implicated in Th2 locus expres-
sion (21). SATB1 was specifically induced, both in WT and
CTCF-deficient Th2 cultures (Fig. 9C).
Taken together, these data indicate that differentiating CTCF-
deficient Th2 cells show impaired expression of Th2 cytokines
IL-4, IL-5, and IL-13, but nevertheless up-regulate the Th2-spe-
cific factors GATA3 and SATB1 and down-regulate T-bet and
STAT4.
Discussion
The differentiation process of naive CD4� T cells to Th1 or Th2
cells is critically dependent on coordinated transcriptional regula-
tion of cytokine gene loci (18). To investigate whether CTCF reg-
ulates transcription of cytokine-encoding genes, we studied mice
in which CTCF was conditionally deleted in the T cell lineage. Our
data indicate that CTCF deficiency affects differentiation of Th2
effector cells by impairing T cell activation as well as Th2 cytokine
production. Activation and proliferation of CTCF-deficient CD4
and CD8 cells upon anti-CD3/anti-CD28 stimulation in vitro was
severely hampered. However, when TCR signaling was circum-
vented with phorbol ester and ionomycin, we observed prolifera-
tion of CTCF-deficient T cells, enabling the analysis of Th cell
differentiation. We found that in CTCF-deficient Th2 polarization
cultures, transcription of IL-4, IL-5, and IL-13 was strongly re-
duced. By contrast, CTCF deficiency had only a modest effect on
IFN-� production in Th1 cultures and did not appear to affect Th17
differentiation and IL-17 production. In CTCF-deficient Th2 cul-
tures, cells were polarized toward the Th2 lineage, as the key tran-
scriptional regulators GATA3 and SATB1 were induced and T-bet
and STAT4 were down-regulated. Nevertheless, expression of
IL-4, IL-5, and IL-13 remained strongly inhibited in these other-
wise Th2-polarized cells. We therefore propose that CTCF plays a
major role in the GATA3- and SATB1-dependent regulation of the
expression of genes within the Th2 cytokine locus.
We found that CTCF-deficient CD4� and CD8� T cells have
severely defective activation and proliferation in response to anti-
CD3/CD28 stimulation. Nevertheless, one of the most important
downstream events, production of IL-2, was not noticeably af-
fected, ruling out global defects in TCR clustering, actin polymer-
ization, or activation of NFAT, NF-�B, and JNK cascades (50, 51).
The finding that PMA/ionomycin stimulation bypassed the CD3/
CD28-signaling defect suggests that the presence of CTCF is im-
portant for signaling events downstream of the TCR which are
necessary for full T cell activation. In this context, we found that
PMA/ionomycin partially (in CD4� T cells) or completely (in
CD8� T cells) rescued the defective induction of IL-2R expression
in CTCF-deficient T cells observed upon anti-CD3/CD28 stimu-
lation (Fig. 5B). Additional experiments are required to clarify
whether CTCF controls gene expression of specific proteins in-
volved in proximal signaling events (induced upon TCR stimula-
tion) that regulate IL-2R induction.
FIGURE 9. GATA3 and SATB1 are induced in CTCF-deficient Th2
cultures. A, Flow cytometric analysis for intracellular GATA3 protein ex-
pression in PMA/ionomycin-stimulated T cell cultures. CD4� T cells were
gated and for the indicated mice expression profiles are displayed as his-
tograms overlays of Th1 (gray histograms) and Th2 cultures (bold lines).
B, Quantitative RT-PCR analysis of GATA3, T-bet, and STAT4 expression
in different T cell cultures from WT (�) or CD4-Cre Ctcff/f mice (f).
Expression levels were normalized for GAPDH and are expressed as ar-
bitrary units, whereby expression in WT Th1 cells (T-bet, STAT4) or Th2
cells (GATA3) was set to 1. Mean values and SD are given for four mice
analyzed per group. C, Western blotting analysis of SATB1 and CTCF
protein levels in PMA/ionomycin-stimulated T effector cell cultures at day
7. Fibrillarin was used as a loading control.
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The in vitro Th1 polarization cultures showed that CTCF-defi-
cient Th1 effector cells produced significant amounts of IFN-�, but
expression was reduced when compared with WT. Also, in anti-
CD3/CD28-stimulated CTCF-deficient CD8� T cells, we found
that the proportion of IFN-�� cells was �60% of that in WT cells
(C. R. de Almeida, unpublished data). In contrast, we observed a
small cloud of IFN-�� cells in Th17 cultures from CTCF-deficient
T cells, which was not detectable in WT Th17 cultures, indicating
that IFN-� expression is not reduced under all culture conditions.
Therefore, we conclude that the observed reduction of IFN-� pro-
duction in CTCF-deficient Th1 cells does not necessarily implicate
CTCF in transcriptional regulation of the IFN-� locus, as de-
creased IFN-� production may well result form reduced expression
of essential transcription factors such as T-bet and STAT4
(Fig. 9B).
Our analysis of CTCF binding in the Th2 cytokine locus re-
vealed four CBS: three sites flanking the Th2 locus (CBS-6 and
CBS-7 upstream of the Il-5 gene, CBS-1 downstream of Il-4,
within the Kif3a gene) and one site in the intergenic region be-
tween Il-13 and Il-4 (CBS-3), irrespective of Th1 or Th2 polar-
ization. CBS-3 is located near the conserved noncoding sequence
CNS-1, which is critical for Th2 cytokine expression and binds the
C-terminal zinc finger of GATA3 (43, 44). However, because the
distance between CNS-1 and CBS-3 is �1 kb, it is not very likely
that CTCF binding to CBS-3 influences Th2 cytokine expression
by direct interaction with nuclear proteins recruited to the CNS-1
region.
Interestingly, CBS-3 is located at the constitutive hypersensitive
site HSS-3, which has been shown to be present both in naive
CD4� cells and Th1 and Th2 cells (43). Although nine SATB1
sites were identified in the mouse Th2 locus (21), none of these is
located near the CNS-1 region. Thus, SATB1 and CTCF binding
sites in the Th2 locus are interspersed. One of the possible expla-
nations for defective Th2 cytokine expression in the absence of
CTCF would be that CTCF is involved in chromatin organization
of the Th2 locus. In such a model, loss of CTCF would affect
SATB1-mediated looping of the Th2 locus and, consequently, Th2
cytokine expression. Indeed, studies in the chicken �-globin locus
have led to a model of CTCF-dependent enhancer-blocking func-
tion based on the interaction between CTCF and the nucleolar
protein nucleophosmin, whereby tethering of the insulator to a
nuclear structure prevents enhancer-promoter communication (52).
Moreover, SATB1 was originally identified as a matrix attachment
region DNA-binding protein (53), which possibly contributes to
chromatin loop organization (54). It would be interesting to inves-
tigate whether CTCF binding sites at the Th2 cytokine locus are
involved in the tethering of this 200-kb DNA region to subnuclear
sites, thereby allowing coordinated expression of Th2 cytokine
genes from a SATB1-dependent, transcriptionally active chroma-
tin structure.
However, mechanisms other than formation of chromatin loops
can also account for CTCF function and explain the defective Th2
cytokine expression observed in the absence of CTCF. Similar to
its role in the mouse �-globin locus (25), CTCF could function to
direct local histone modifications at the Th2 cytokine locus. In-
deed, high-resolution profiling of histone methylation in the human
genome showed that CTCF marks boundaries of histone methyl-
ation domains (30) and CTCF interaction with histones or histone-
modifying proteins have been reported (30, 52, 55, 56). Addition-
ally, CTCF has also been shown to interact with the large subunit
of RNA polymerase II (57), shown to be recruited to the Th2
cytokine locus upon Th2 cell activation (21). Finally, it remains
possible that the effect of CTCF on Th2 cytokine expression is
indirect. For example, CTCF could be an essential regulator of the
expression 1) of nuclear regulators other than GATA3 or SATB1
that are required for Th2 cytokine transcription or 2) of enzymes
involved in posttranslational modifications of Th2-specific tran-
scription factors.
The role for CTCF in the GATA3/SATB1-mediated regulation
of the Th2 cytokine locus may well parallel its recently described
role in the control of MHC class II gene expression and the for-
mation of long-distance chromatin interactions involving the
CIITA (33). In contrast, we reported that deletion of one CTCF
binding site in the mouse �-globin locus did not affect expression
of the �-globin genes (25). Thus, it is clear that CTCF has cell
type-specific functions. It was proposed that CTCF remains bound
to its �14,000 cognate binding sites irrespective of cell type (28).
It will be interesting to determine how CTCF performs cell type-
specific roles while remaining bound to its cognate sites. Equally
interesting are the questions how and which chromosomal inter-
actions, both in cis-and in trans, persist in the absence of CTCF.
Importantly, our experiments in mature CTCF-negative T cells
show they can proliferate and differentiate under appropriate con-
ditions and it is therefore feasible to address these issues using
CTCF knockdown or conditional targeting approaches.
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GeneRAL DISCuSSIOn AnD FutuRe PeRSPeCtIVeS
The	morphological	and	functional	diversity	of	multi-cellular	organisms	is	a	result	
of	the	precise	and	complex	regulation	of	the	genetic	information	at	different	stages	
of	 cellular	 differentiation.	 Hence,	 different	 levels	 of	 control	must	 exist	 to	maintain	
the	proper	spatio-temporal	expression	of	genes	throughout	the	process	of	cellular	























the role of Delangin in long-range interactions and more
Delangin interactors
Delangin	was	 initially	 identified	as	a	developmental	 regulator	 in	Drosophila.	A	
genetic	screen	aimed	to	isolate	genes	involved	in	long-	range	interactions	between	
promoters	and	remote	enhancers	identified	Nipped-B,	a	regulator	of	the	Ultrabithorax 





The	role	of	Delangin	 in	Drosophila	 in	 long-range	gene	regulation	triggered	our	
interest	in	this	protein.	The	fact	that	Delangin	acts	through	Cohesin,	a	protein	that	is	
involved	in	many	diverse	cellular	processes,	makes	it	complicated	to	reveal	a	specific	
function	 in	a	distinct	process.	The	complexity	of	 the	processes	 involving	Delangin	
requires	both,	biochemical	and	genetic	approaches	to	clarify	the	function	of	Delangin	
in	mammals.	The	genetic	approach	is	described	in	Chapter	3,	while	a	biochemical	
approach	was	not	advanced	enough	 to	be	 included	and	will	be	described	 in	 this	
Chapter.	
Protein-protein	 interactions	are	crucial	 in	most	biological	processes,	 including	
gene	 regulation	and	cell	cycle	progression.	Most	proteins	 function	as	multiprotein	
complexes	or	 interact	with	multiprotein	complexes.	 Identification	of	protein-protein	
interactions	 in	 the	 context	 of	 their	 physiologically	 relevant	 complexes	 is	 therefore	
a	 key	 to	 fully	 understand	 the	 cellular	machinery.	Many	 experimental	 approaches,	
including	yeast	two-hybrid	analysis,	mass	spectrometry	and	affinity	purification	have	
been	developed	for	the	detection	and	identification	of	interacting	proteins	in	a	cellular	

























Metastasis	 tumor	 antigen	 1	 (MTA1),	 a	 candidate	member	 of	 the	metastasis-
associated	 gene	 family,	 is	 a	 component	 of	 the	 nucleosome	 remodeling	 and	
deacetylating	 (NuRD)	 complex.	 The	 NuRD	 complex	 has	 been	 implicated	 in	 ATP-
dependent	 chromatin	 remodeling	 and	 transcriptional	 regulation.	 As	 a	 part	 of	 the	
NuRD	complex,	MTA1	is	thought	to	modulate	transcription	by	influencing	chromatin	
remodeling	 	 (Kumar	 et	 al.,	 2003;	 Toh	 et	 al.,	 1994).	 We	 were	 able	 to	 detect	 an	
interaction	 of	 endogenous	Delangin	 only	with	MTA1,	while	 the	 other	 components	








two	 different	 systems.	 Another	 interesting	 set	 of	 interactions	 is	 found	 between	
Cohesin	 and	 a	 Chromatin-remodeling	 complex	 containing	 the	 ATPase	 SNF2h	 in	
human	cells	(Hakimi	et	al.,	2002).	Although	the	interplay	of	chromatin	structure	and	







In	 addition	 to	 its	 role	 in	 histone	 deacetylation	 and	 a	 strong	 correlation	 with	






to	 identify	 additional	 targets	 of	MTA1	and	correlate	 them	with	Delangin	 targets	 in	




single	 interactions	 to	 a	more	 complex	 picture.	ChIP-sequencing,	which	 combines	
chromatin	 immunoprecipitation	 (ChIP)	 with	 massively	 parallel	 DNA	 sequencing,	
can	be	used	to	precisely	map	global	binding	sites	 for	any	protein	of	 interest.	This	
technique	gives	numerous	opportunities	 for	 identification	of	binding	sites	of	many	
factors	 that	 bind	directly	 or	 indirectly	 to	DNA.	 In	 the	 case	of	 indirect	 binding,	 the	




DNA	 Topoisomerase	 II	 α	 is	 another	 protein	 that	 was	 identified	 by	 mass-
spectrometry	 and	 confirmed	 to	 interact	 with	 endogenous	 Delangin.	 Interestingly,	
coimmunoprecipitation	 experiments	 indicate	 that	 HDAC1	 and	 HDAC2	 are	 also	
associated	with	Topo	II	α in vivo	under	normal	physiological	condition.	Complexes	
containing	Topo	II	α	possess	HDAC	activity,	and	complexes	containing	HDAC1	and	
















development,	albeit	 has	 to	persist	 for	 several	decades.	During	 this	 time,	Cohesin	















of	 many	 genes.	 Hence,	 it	 is	 important	 to	 identify	 the	 genes	 whose	 transcription	





way	 but	 rather	 in	 structural	 way	 to	 Delangin.	 For	 example,	 by	 having	 regulatory	
enhancers	near	to	Cohesin	binding	sites.




changes	should	be	monitored	 in	 the	organs	before	 they	are	affected	or	 in	organs	
that	are	not	affected	since	it	is	necessary	to	avoid	the	results	of	ongoing	pathological	























relocated	 from	 the	 initial	 binding	 site	 once	 the	 loading	 reaction	 takes	place.	One	
possibility	 is	 that	Cohesin	 is	 removed	 from	DNA	and	subsequently	 reloaded.	This	
scenario	is	less	probable	since	Delangin	would	be	needed	for	reloading	of	Cohesin	
and	that	is	not	the	case	since	Delangin	is	not	found	at	the	final	destination.	Another	







contact	 DNA	 (Nasmyth	 et	 al.,	 2000).	 Consistent	 with	 this	 possibility,	 recombinant	
fragments	of	SMC3	and	purified	Cohesin	core	complexes	can	bind	to	DNA	 in vitro	
(Losada	and	Hirano,	2001)	with	a	 low	affinity	and	 in	an	ATP	 independent	manner	
unlike	Cohesin	 loading	 in vivo.	Therefore,	 it	 is	unknown	whether	 these	 interactions	
reflect	 how	Cohesin	 associates	 with	 DNA	 in vivo.	 According	 to	 the	 “ring”	model,	







































throughout	 mammalian	 genomes	 can	 be	 used	 to	 address	 the	 question	 of	 the	
importance	of	CTCF	and	Cohesin	cooperation	to	regulate	gene	transcription	through	





Alternatively,	 indirect	 interactions	via	other	proteins	or	DNA	might	be	necessary	 to	
mediate	 their	 communication.	 More	 sensitive	methods	 in	 combination	 with	 Chip-
sequencing	should	be	used	to	answer	this	question.
The	knockdown	of	CTCF	substantially	reduced	the	association	of	the	Cohesin	
complex	with	 its	genomic	 target	 loci	but	not	 the	overall	 binding	on	 the	chromatin	
(Wendt	et	al.,	2008).	This	observation	suggests	that	CTCF	binding	sites	are	“meeting	
points”	 for	 those	 two	 factors.	 Depletion	 of	 CTCF	 binding	 motifs	 abolishes	 the	
association	(Stedman	et	al.,	2008)	while	Cohesin	depletion	had	no	(Parelho	et	al.,	
2008)	or	a	moderate	(Wendt	et	al.,	2008)	effect	on	CTCF	binding.
The	next	step	 is	of	course	 to	determine	 the	 functional	 relevance	of	CTCF	and	
Cohesin	 shared	 binding	 sites	 with	 respect	 to	 gene	 expression.	 CTCF	 was	 first	
described	for	its	role	in	regulation	of	the	c-myc	gene	(Lobanenkov	et	al.,	1990),	an	its	
role	in	insulation	was	later	demonstrated	for	multiple	vertebrate	insulators,	including	
the	β-globin	and	H19/Igf2	 locus.	Using	 reporter	assays,	Wendt	et	al.	showed	 that	
Cohesin	regulates	the	endogenous	H19/Igf2	insulator	in	HeLa	cells.
One	 question	 is	 how	 Cohesin	 contributes	 to	 the	 insulator	 function?	 One	 of	
the	 possibilities	 is	 that	 Cohesin	 stabilizes	 long-range	 chromosomal	 interactions	
mediated	 by	 CTCF.	 A	 generally	 accepted	 idea	 is	 that	 CTCF	 forms	 chromosome	
loops	 that	 facilitate	 some	 enhancer-promoter	 interactions	 and	 prevent	 others	




locus	 (Splinter	 et	 al.,	 2006).	 Since	 Cohesin	 accumulates	 at	 CTCF-binding	 sites,	




regulate	 long-range	 interchromosomal	 loops.	Performing	3C	assays	 in	 the	 set	 up	
where	Cohesin	and/or	CTCF	are	depleted	should	answer	this	question.	Even	though	
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units	 called	 chromosomes.	 These	 are	 the	 essential	 units	 for	 cellular	 division	 and	
must	be	replicated,	divided,	and	passed	successfully	to	the	daughter	cells.	They	are	
packaged	by	proteins	into	a	condensed	structure,	called	chromatin,	which	enables	





long-range	 interactions	 between	 distant	 regulatory	 elements,	 and	 the	 genes,	 are	
responsible	 for	 the	specific	expression	of	many	developmentally	 regulated	genes.	

















































van	 een	 organisme	 is	 opgeslagen	 in	 miljoenen	 DNA	 basenparen.	 In	 eukaryoten	








door	 verscheidene	 algemene	 cel	 en	 stadium	 specifieke	 eiwitten	 die	 binden	 aan	
chromatine	en	DNA.	In	het	DNA	van	metazoans	zijn	interacties	tussen	verscheidene	
regulerende	elementen	en	hun	genen	verantwoordelijk	voor	de	specifieke	expressie	
van	 vele	 ontwikkelingsgereguleerde	 genen.	 Vaak	 vinden	 deze	 interacties	 plaats	
over	 grote	 afstanden,	 in	 sommige	 gevallen	 liggen	 de	 regulerende	 elementen	
zelfs	 honderden	en	 soms	wel	duizenden	 kilobasen	 van	de	desbetreffende	genen	
verwijderd.	Recentelijk	is	er	een	groeiende	interesse	in	deze	regulerende	elementen	
ontstaan	en	in	de	factoren	die	betrokken	zijn	bij	deze	interacties.	In	dit	proefschrift	
worden	een	aantal	 factoren	besproken	die	een	rol	spelen	 in	 interacties	over	 lange	
afstand	en	de	organisatie	van	chromatine.





Hoofdstuk	 2	 beschrijft	 de	 nieuwe	 bindingspartners	 van	 Ldb1.	 Ldb1	 is	 een	





















om	 zijn	 rol	 in	 zuster	 chromatide	 cohesie,	 en	 CTCF,	 het	meest	 bekende	 insulator	












In	 hoofdstuk	 6	 wordt	 de	 functionele	 interactie	 tussen	 Delangin	 en	 Cohesin	
besproken.	Ook	wordt	de	functionele	relevantie	van	de	gedeelde	Cohesin	en	CTCF	
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